Improving Self-Care Measures of Hypertension Through Implementation of an Education and Action Plan by Huffaker, Crystal Celeste
UNLV Theses, Dissertations, Professional Papers, and Capstones 
5-1-2021 
Improving Self-Care Measures of Hypertension Through 
Implementation of an Education and Action Plan 
Crystal Celeste Huffaker 
Follow this and additional works at: https://digitalscholarship.unlv.edu/thesesdissertations 
 Part of the Medical Sciences Commons, and the Nursing Commons 
Repository Citation 
Huffaker, Crystal Celeste, "Improving Self-Care Measures of Hypertension Through Implementation of an 
Education and Action Plan" (2021). UNLV Theses, Dissertations, Professional Papers, and Capstones. 
4152. 
https://digitalscholarship.unlv.edu/thesesdissertations/4152 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by Digital 
Scholarship@UNLV with permission from the rights-holder(s). You are free to use this Dissertation in any way that 
is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to 
obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons 
license in the record and/or on the work itself. 
 
This Dissertation has been accepted for inclusion in UNLV Theses, Dissertations, Professional Papers, and 
Capstones by an authorized administrator of Digital Scholarship@UNLV. For more information, please contact 
digitalscholarship@unlv.edu. 
 
IMPROVING SELF-CARE MEASURES OF HYPERTENSION THROUGH 










Bachelor of Science- Nursing 
Brigham Young University 
2005 
 
Master of Science- Nursing 






A doctoral project submitted in partial fulfillment 








School of Nursing 












Doctoral Project Approval 
The Graduate College 
The University of Nevada, Las Vegas 
        
March 10, 2021
This doctoral project prepared by  
Crystal Celeste Huffaker  
entitled  
Improving Self-Care Measures of Hypertension Through Implementation of an Education 
and Action Plan  
 
 
is approved in partial fulfillment of the requirements for the degree of 
Doctor of Nursing Practice 
School of Nursing 
 
                
Cheryl Maes, Ph.D.         Kathryn Hausbeck Korgan, Ph.D. 
Examination Committee Chair     Graduate College Interim Dean 
 
Alona Dalusung-Angosta, Ph.D. 
Examination Committee Member 
        
Jay Shen, Ph.D  






Hypertension (HTN) is a leading cause of morbidity and mortality worldwide and one of the 
most common conditions seen by primary care providers. Current clinical practice guidelines 
recommend lifestyle modifications for patients with elevated blood pressure (BP) and diagnosed 
HTN. Despite these recommendations, many patients diagnosed with HTN make insufficient 
modifications to their lifestyle. The purpose of this project was to determine the impact of 
implementing an education session, with development of a patient action plan, along with 4-
week, 8-week, and 12-week follow-ups on the adoption of self-care measures for HTN. 
Participants had their BP, height, and weight measured along with completing the Hypertension 
Self-Care Profile (HBP-SCP) Behavior questionnaire. The participants then underwent a 45-60-
minute education session along with developing self-care goals for HTN. Participants received a 
4-week and 8-week telephone follow-up. At 12-weeks participants had their biometric readings 
repeated and the HBP-SCP completed post-intervention. Paired t-test results were significant for 
improvement in the HBP-SCP scores post-intervention (p=.001). The participants had a mean 
improvement in BP but a mean increase in weight. Findings from this Doctor of Nursing Practice 
project indicate an education session, with development of an action plan and frequent follow-
ups, does increase a patient’s adoption of self-care measures for HTN. Therefore, self-care 
measures are an important component of the treatment plan for patients with HTN and should be 
a focus for healthcare providers.  
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Chapter I  
Introduction/Background 
Hypertension (HTN) is a leading cause of morbidity and mortality worldwide. It is 
estimated that greater than 40% of the adult global population has HTN, and this rate is expected 
to increase in the future (Caligiuri & Allen, 2017). In the United States, the current rates of HTN 
among adults are even higher; estimates reaching as high as 46% (Whelton et al., 2018). To add, 
the risk of developing HTN increases with age. For those between the ages of 55 and 65 who do 
not have HTN, 90% eventually develop it during their lifetime (Whelton et al., 2018).  
HTN is associated with increased development of other disease states including but are 
not limited to myocardial infarction (MI), chronic kidney disease (CKD), stroke, heart failure, 
and even death (Rivera et al., 2019). According to the Centers for Disease Control and 
Prevention (CDC, 2016), seven out of ten people with their first MI, eight out of ten people with 
their first stroke, and seven out of ten people with chronic heart failure also have HTN. 
Furthermore, elevated blood pressure (BP) is the leading cause of death worldwide (Whelton et 
al., 2018). In 2015, HTN was attributed to 10.7 million deaths and a loss of 211.8 million 
disability life years (Roerecke et al., 2017). The high mortality and morbidity profile of HTN can 
also create a huge financial and emotional burden on the patient, their family, and society 
(Farazian et al., 2019). Unfortunately, it is estimated by the year 2035 the cost of HTN will reach 
$221 billion (Benjamin et al., 2019).  
Problem and Significance 
      Due to the high prevalence rate, associated comorbidities, and cost, HTN is an important 
disease state for healthcare providers and patients to manage. HTN is considered one of the most 




were eliminated, it would decrease the mortality rates of cardiovascular disease (CVD) by 30.4-
38% (Benjamin et al., 2019). Despite the impact HTN has on patients and our society, 
approximately only 49.3% of males and 55.2% of females have their HTN well-controlled 
(Whelton et al., 2018). Considering that HTN is the most common condition seen by primary 
care providers (James et al., 2014), they are poised to assist patients in managing their HTN 
through recommended clinical practice guidelines. Current clinical practice guidelines 
recommend lifestyle modifications for patients with elevated BP, stage 1 HTN, and stage 2 HTN; 
whereas, medications for patients with stage 1 HTN with an estimated 10-year cardiovascular 
disease risk, and all patients with stage 2 HTN (Whelton et al., 2018). Despite these 
recommendations, many patients diagnosed with HTN make insufficient modifications to their 
lifestyle (Kilic et al, 2018). It is estimated that less than 10% of the patients with HTN adhere to 
dietary recommendations and only 35% of patients exercise on a regular basis (Friedberg et al., 
2015). Moreover, patients fail to follow recommended medication treatment plans with 
adherence rates to medication regimens found to be as low as 18.8% (Caligiuri & Allen, 2017). 
Unfortunately, medication non-adherence has been found to result in poor treatment outcomes 
and added healthcare costs (Yue et al., 2015). 
         There is support increased patient self-care measures can improve adherence not only to 
pharmacologic but also non-pharmacologic treatment recommendations and HTN outcomes. Lee 
and Park (2017) reported self-care behaviors were higher in patients with controlled HTN and 
lower in patients with uncontrolled HTN. In addition, patients who participate in self-care 
measures were better able to manage their BP, reduced emergency room visits by 40%, and 
reduced outpatient visits by 17% (Golshahi et al., 2015). Self-care measures effective in reducing 




Hypertension (DASH) diet plus sodium reduction, dietary potassium intake, physical activity, 
moderation in alcohol intake, and medication adherence (Whelton et al., 2017). It is supported 
self-monitoring of BP, in combination with other interventions, allowed those with HTN reach 
their BP goals within a 6-12-month timeline (Whelton et al., 2017). To illustrate, weight loss 
results in an approximate 5 mm Hg decrease in systolic blood pressure (SBP), 11 mm Hg 
decrease for DASH diet, 5-6 mm Hg decrease for sodium reduction, 4-5 mm Hg decrease for 
enhanced potassium intake, 4-8 mm Hg decrease for physical activity, and 4 mm Hg decrease for 
moderation in alcohol intake (Whelton et al., 2017).  Furthermore, medication adherence reduces 
SBP by approximately 9 mm Hg (Caligiuri & Pierce, 2017).  
Collaboration between the patient and the primary care provider is not only essential to 
improve the patient’s knowledge of HTN but also adherence to the aforementioned self-care 
measures. Likewise, experts recommend patients with HTN receive counseling to make the 
necessary lifestyle changes for better HTN control (Dye et al., 2015). Quality improvement 
interventions at the provider-patient level have shown an ability to achieve better BP control in 
patients (Whelton et al., 2017). However, despite the high comorbidities and cost associated with 
HTN very few patients have their BP controlled. Therefore, self-care measures are an important 
step in the management of HTN and can effectively lower BP and should be used as first line 
treatment or in conjunction with medication. 
Purpose 
         The purpose of this Doctor of Nursing Practice (DNP) project is to develop, implement, 
and evaluate an educational intervention and patient action plan to increase self-care measures 
for patients 35-55 years old with diagnosed essential HTN. 





       The mission for this DNP project is to implement a sustainable education program to 
improve patients’ knowledge of HTN as well as increase use of self-care measures to aid in 
lowering BP.  
Goal 
The goal of this DNP project  will be to incorporate the latest evidence-based research 
and clinical practice guidelines on self-care measures that have proven effective in lowering BP 
and encourage patient adoption of these changes through the development of a patient action 
plan to be  used and continued within the identified setting.  
Objective 
This DNP project will focus on educating participants on HTN and the incorporation of 
self-care measures to improve BP.  Each participant will complete the Hypertension Self-Care 
Profile (HBP-SCP) questionnaire regarding their current self-care measures for HTN at the 
beginning of the project along with measurement of height, weight, body mass index (BMI), and 
BP. The patient will then participate in an individual-based education session with the DNP 
author. The education session will include information regarding HTN based on current clinical 
practice guidelines, as well as complications of HTN, and evidence-based self-care measures, to 
lower BP. During that time the patient will complete an action plan of goals that they will 
incorporate over the next 3 months to improve their self-care measures. The participants will 
receive 2 follow up phone calls from the DNP author; spaced 1 and 2 months after their 
education session for any questions to be answered or support needed. Lastly, the participants 
will have an in-person follow up with the DNP author at 3 months in which they will complete 




Significance of Doctor of Nursing Practice Project to Advanced Practice Nursing  
     There are an increasing number of advanced practice registered nurses licensed to 
practice. An example of an advanced practice registered nurse is a nurse practitioner (NP) in 
which the number one service they provide is counseling and education (AANP, 2019). The 
latest survey from the American Academy of Nurse Practitioners (AANP) indicate there are over 
270,000 licensed NPs in the United States of which 72.6% work in a primary care setting 
(AANP, 2019). With this said, NPs are working in settings where they will be expected to treat 
HTN. Accordingly, it is important NPs are aware of current clinical practice guidelines regarding 
the treatment of HTN and self-care measures which will benefit their patients so they can 







This chapter presents an overview of hypertension and a review of the literature for the 
Doctor of Nursing Practice (DNP) project. A search of several databases was completed for 
studies published within the last ten years and in the English language.  The Cumulative Index of 
Nursing and Allied Health Literature (CINAHL), Cochrane Database, and PubMed were 
searched using keywords including hypertension, high blood pressure, education, self-care, self-
management, lifestyle modifications, Dietary Approaches to Stop Hypertension (DASH) diet, 
sodium restriction, low sodium diet, physical activity, weight loss, exercise, alcohol, medication 
adherence, and self-monitoring. Articles were included that assessed the effect of one or more of 
the aforementioned lifestyle choices on a participant’s blood pressure and articles that assessed 
the effect of an educational intervention by a healthcare provider on a participant’s blood 
pressure and/or self-care measures. A total of 40 articles were included in the literature review 
(see Appendix A).  
Background, Diagnosis, and Risk Factors of Hypertension  
     Blood pressure can be described as the amount of pressure blood is exerting on the walls 
of the arteries in the body. Blood pressure (BP) readings are comprised of both systolic and 
diastolic readings; a systolic reading is the amount of pressure exerted on the arteries when the 
heart is beating while the diastolic reading is the amount of pressure exerted with the heart at rest 
(CDC, 2020). Hypertension (HTN) may be diagnosed if the blood pressure reading is 
consistently elevated above normal levels and can be either essential, multifactorial in cause, or 
secondary with a clearly defined cause. Most patients with HTN have essential HTN (Maranta et 




tone due to adrenergic factors, over activation of the renin/angiotensin/aldosterone system, and 
sodium retention as a result of renal-adrenal changes (Maranta et al., 2016). Each of these 
systems seem to affect the other with alterations in one leading to abnormal changes in another 
contributing further to elevation in BP readings (Maranta et al., 2016).  
According to the latest clinical practice guidelines through the American College of 
Cardiology (ACC) and the American Heart Association (AHA) Task Force a normal BP 
category is considered less than 120/80 mm Hg, with elevated BP considered when the SBP is 
between 120-129 mm Hg and the diastolic blood pressure (DBP) is less than 80 mm Hg 
(Whelton et al., 2017). A patient should be diagnosed with stage 1 HTN with an SBP between 
130-139 mm Hg or DBP between 80-89 mm Hg and stage 2 HTN with an SBP greater than or 
equal to 140 mm Hg or DBP greater than or equal to 90 mm Hg (Whelton et al., 2017). This 
differs from the Seventh Report of the Joint National Committee on the Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC 7). JNC 7 considers a normal BP below 
120/80 mm Hg, prehypertension to be a SBP between 120-139 mm Hg or DBP between 80-89 
mm Hg, stage 1 HTN diagnosed with a SBP between 140-159 mm Hg or DBP between 90-99 
mm Hg, and stage 2 HTN with a SBP greater than or equal to 160 mm Hg or DBP greater than or 
equal to 100 mm Hg (Jackson et al., 2008). The JNC 8 guidelines did not address diagnosis of 
HTN but agreed with the JNC 7 guidelines that a BP reading of 140/90 mm Hg is a reasonable 
definition of high BP (James et al., 2014). 
The 2017 ACC/AHA clinical practice guidelines affect the prevalence rate of HTN by 
increasing it from 32% according to JNC 7 guidelines to 46% (Whelton et al., 2018). According 
to the 2017 ACC/AHA clinical practice guideline the prevalence of HTN in males and females 




85% by the age of 75 or older (Whelton et al., 2018).  Prevalence of HTN increases dramatically 
starting at age 35 with a prevalence rate for 35 to 44-year-old males and females at 42.5% and 
31.6% compared to the prevalence rates for 20 to 34 year-old males and females of 25.7% and 
13.0% (Virani et al., 2020). The risk of complications from hypertension increases three-fold 
when a patient has had a 7-year duration of hypertension (Abegaz et al., 2017). Treatment for 
HTN is recommended to get to a target BP of less than 130/80 mm Hg, in patients 65 or older 
with a high comorbidity burden and decreased life expectancy a risk benefit analysis should be 
completed to assess target BP for the patient (Whelton et al., 2018).  
There are both unmodifiable and modifiable risk factors for the development of HTN. 
Unmodifiable risk factors include genetics or family history of HTN, age, gender, and race or 
ethnicity (CDC, 2020). A genetic predisposition can be seen in patients, but it is a small effect 
accounting for only 3.5% variability in BP readings (Whelton et al., 2018). The risk of 
developing HTN increases with age, with 9 out of 10 people developing HTN in their lifetime 
(CDC, 2020). The prevalence of HTN between the ages of 20 to 44 in men and women is 30% 
and 19% respectively and increases to 79% and 85% by the age of 75 (Whelton et al., 2020). 
Gender factors into the onset of HTN with the risk of HTN higher in men than women below the 
age of 75 but higher in women than men over 75 years old (Whelton et al., 2018). There is also 
an increased risk of HTN depending on a patient’s race or ethnicity. Non-Hispanic black males 
and females have the highest prevalence rates at 59% and 56%, while Non-Hispanic Asians have 
the lowest prevalence rate with 44% in men and 32% in women (Whelton et al., 2018).  
Modifiable risk factors that contribute to HTN development include diets high in sodium 
and low in potassium, physical inactivity, obesity, excess alcohol use, and tobacco use (CDC, 




can help prevent as well as treat HTN (Whelton et al., 2018). An increase in target organ damage 
is seen patients that are not treated according to hypertension guidelines (Abegaz et al., 2017). 
Self-Care Measures 
Diet 
Dietary changes have been studied extensively concerning their effect on blood pressure 
in both normotensive and hypertensive patients, specifically regarding the DASH diet. The 
DASH diet is high in fruit, vegetable, whole grain, and low-fat dairy products with a reduction in 
saturated fat and total fat (Whelton et al., 2018). To illustrate, Saneei and colleagues (2014) 
conducted a meta-analysis examining the DASH diet for reducing blood pressure (BP) indicating 
an overall reduction of systolic BP (SBP) by 6.74 mm Hg and by 3.54 mm Hg for DBP (see 
Appendix A). Moreover, the decrease in SBP was found to be greater in participants who had a 
higher baseline BP at the start of the studies, with the reduction increasing by 0.05 mm Hg for 
every 1-unit elevation in BP at baseline (Saneei et al., 2014).  
The effect of the DASH diet is also significant for hypertensive patients with metabolic 
syndrome. Specifically, the DASH diet reduces the SBP by 5.5 mm Hg in patients with HTN and 
metabolic syndrome (Appendix A) and by 6.8 mm Hg in patients without metabolic syndrome 
(Hikmat & Appel, 2014). This is an important finding since metabolic syndrome has been shown 
to decrease the effect of anti-hypertensive medication treatment (Hikmat & Appel, 2014). 
Furthermore, Juraschek and colleagues (2017) reported a correlation between baseline SBP and 
reduction in BP for participants on the DASH diet with or without a sodium restriction. 
Additionally, those on a DASH diet with average sodium intake and a baseline SBP of 150 or 
greater, had a reduction of their SBP by 10.6 mm Hg compared to those with a baseline SBP less 




magnified with the addition of a sodium restriction to less than 1,150 mg a day with the DASH 
diet (Appendix A). Participants with a baseline SBP 150 mm Hg or greater saw a reduction in 
their SBP by 20.8 mm Hg compared to participants on a control diet with average sodium intake 
(Juraschek et al., 2017).  
Sodium restriction alone has also been found to reduce BP. He and colleagues (2013) 
conducted a meta-analysis investigating sodium reduction alone on BP, this showed a decrease in 
SBP of 5.39 mm Hg and DBP of 2.8 mm Hg in participants with HTN.  In addition, potassium 
supplementation reduces SBP and DBP by 4.4 mm Hg and 2.4 mm Hg respectively based on a 
meta-analysis involving both normotensive and hypertensive patients (Mahmoud et al., 2019). 
Furthermore, Binia and colleagues (2015) found potassium supplementation reduced SBP in 
hypertensive patients by 6.8 mm Hg (see Appendix A). The study found this may be related to a 
reduction in the sodium-potassium ratio to levels of 1:1 compared to a typical American diet of 
greater than 3:1 (Binia et al., 2015). This corresponds with study findings by Huggins and 
colleagues (2011) who suggest a diet higher in potassium and magnesium showed a significant 
drop in SBP of 6.2 mm Hg for hypertensive patients currently treated with antihypertensive 
medication. Current clinical guidelines recommend at least a 1,000 mg per day reduction in 
sodium intake for patients with HTN with the optimal goal being less than 1,500 mg per day of 
total sodium intake and a total daily intake of dietary potassium of at least 3,500 mg (Whelton et 
al., 2018). 
Weight Reduction 
 Unfortunately, obesity is associated with a higher prevalence of HTN with rates 
estimated at 60-77% (Fantin et al., 2019). A body mass index (BMI) of 30 kg/m² is defined as 




adipokines, cytokines and alterations in normal neurohumoral pathways and metabolic functions 
that promote the development of HTN (Kotsis et al., 2018). It is known weight loss reduces 
BP.  Studies analyzing weight loss from lifestyle modifications, pharmacological treatments, and 
bariatric surgery show an associated decrease in BP (Fantin et al., 2019). Kyriazis and colleagues 
(2014) found a reduction in BMI by 2.8 kg/m² in obese males and 1.3 kg/m² in obese females 
resulted in SBP reduction of 15 mm Hg and 6 mm Hg respectively (see Appendix 
A).  Furthermore, Blumenthal and colleagues (2010) reported weight loss of an average of 8.7 kg 
along with the DASH diet resulted in a decrease in SBP of 16.1 mm Hg and DBP of 9.9 mm 
Hg. Patients who are overweight should be encouraged to aim for at least a 1 kg weight loss and 
ideally more until they reach their optimal body weight (Whelton et al., 2018). 
Physical Activity 
Physical activity has been found to protect against the development of HTN as well as 
reduce BP in patients with HTN (Bakker et al., 2018). To illustrate, walking decreased BP in 
patients with HTN, in addition to a reduction in ambulatory SBP and DBP of 5.9 mm Hg and 3.3 
mm Hg respectively was found with treadmill exercise done three times a week (Dimeo et al., 
2012). Moreover, Paula and colleagues (2015) reported an increase of walking 15-20 minutes 
more a day along with the DASH diet reduced SBP and DBP by 12 mm Hg and 11 mm Hg 
respectively.  Additionally, those with resistant HTN, who participated in one session of light 
intensity exercise reduced their SBP by an average of 7.7 mm Hg (see Appendix A) and the post-
exercise hypotension effect continued for 19 hours after the exercise session (Santos et al., 
2016). It is recommended that patients with HTN exercise most days of the week due to the post-




at least 150 minutes a week of moderate intensity or 90 minutes a week of high intensity aerobic 
activity or dynamic resistance exercise (Whelton et al., 2018).  
Alcohol Reduction 
Moderate to high alcohol consumption is associated with an increased prevalence of 
HTN. Men with moderate (5-30 grams/day) and high (>30 grams/day) alcohol consumption had 
an increased prevalence of HTN, while women with high (>15 grams/day) alcohol consumption 
had an increased prevalence of HTN (Yoo et al., 2019). The prevalence of HTN in men with 
high-risk drinking patterns is 40.4%; whereas, in women it is 32.3% (Hong et al., 2016).  
 Individuals with increased alcohol use had a reduction in BP when they decreased their 
alcohol intake. To illustrate, Roerecke and colleagues (2017) conducted a meta-analysis and 
found those who consumed six or more drinks a day reduced their SBP and DBP by 5.5 mm Hg 
and 3.97 mm Hg when they decreased their alcohol consumption by 50% (see Appendix A). 
Furthermore, the reduction in BP was dose-dependent based on alcohol consumption at baseline 
with participants who consumed three drinks a day, reduced to near abstinence, only had a 1.18 
mm Hg reduction in SBP and 1.09 mm Hg in DBP (Roerecke et al., 2017). Current clinical 
practice guidelines for HTN recommend moderation in alcohol intake defined as less than or 
equal to 2 drinks a day for men and less than or equal to 1 drink a day for women (Whelton et al., 
2017). 
Smoking Cessation 
     HTN and smoking are 2 risk factors for the development of cardiovascular disease 
(CVD), and that risk increases for a patient if they have HTN and are a current smoker (Lim et 
al., 2012). Lim and colleagues found that the risk of mortality from CVD increased in patients 




was consistent with Ge and colleagues (2012) who found that the combination of a heavy pack 
year smoking history and elevated blood pressure led to higher mortality rates from not only 
CVD but all lead to mortality (see Appendix A). 
    Smoking has also been associated with a higher prevalence of HTN. Patients who smoke 
for a longer duration and have an increased lifetime cigarette consumption have a higher 
prevalence of HTN (Thuy et al., 2010). Patients who had a heavy consumption of cigarettes 
defined as greater than 20 cigarettes a day had a higher prevalence of HTN compared to patients 
who had moderate (11-20 cigarettes a day) and light (1-10 cigarettes a day) consumption of 
cigarette smoking (Feng et al., 2013).  
     Patients should be encouraged to reduce their cigarette consumption and quit smoking to 
reduce their risk of CVD and mortality.  
Self-monitoring 
Self-monitoring of BP refers to a patient checking their BP at home or another place 
outside of the clinic setting. It is recommended that a patient check their BP at least weekly 
before clinic appointments with their provider and following medication changes, with 
preference toward a patient checking their BP every day and keeping an accurate record of their 
BP measurements (Whelton et al., 2018). Home blood pressure monitoring results in improved 
adherence to medication therapies and higher rates of BP control (Stergiou et al., 2014). Agarwal 
and colleagues (2011) conducted a meta-analysis on home BP monitoring that showed a 
reduction in SBP of 2.21 mm Hg (see Appendix A).  In addition, participants were more likely to 
have titration or adjustments in their antihypertensive medication by their healthcare provider if 
they monitored their BP at home (Agarwal et al., 2011). Self-monitoring of BP reduces SBP and 




who received personal support with their lifestyle modifications and self-monitoring reduced 
their SBP and DBP by 6.1 mm Hg and 2.3 mm Hg respectively (Tucker et al., 2017). 
Medication Adherence 
Medication adherence is another component of BP control. Adherence to a treatment 
regimen is defined as the capacity and willingness to comply with a prescribed treatment plan, a 
patient is compliant or adherent to their medication if they take at least 80% of the prescribed 
tablets (Villalva et al., 2016). Yue and colleagues (2015) found those with high adherence to 
medication reduced their mean SBP compared to those with low adherence to medication. 
Factors affecting medication compliance include participants’ knowledge regarding HTN, family 
involvement, and provider involvement in their care (Yue et al., 2015). Non-adherence to 
treatment regimens was found to result in a 6.3 mm Hg higher SBP than in those who adhere to 
their medication regimen (Shaw & Bosworth, 2011). Furthermore, over a 24-month period those 
who did not adhere to their medication regimen had a 7.5 mm Hg increase in their SBP 
(Appendix A) compared to those who did adhere. (Shaw & Bosworth, 2011).  
Lifestyle changes that involve diet, increased physical activity, weight loss, alcohol 
reduction, smoking cessation along with medication adherence reduce a patient’s blood pressure. 
Patients should be encouraged to incorporate these changes and monitor their BP frequently to 
ensure that they are on an appropriate treatment regimen. 
Educational Interventions 
Education interventions, of varying time duration, have been utilized in many studies to 
improve participant’s knowledge of HTN management and lifestyle modifications that can lower 
BP (see Appendix A). A monthly educational session with a nurse for six months showed 




with diagnosed HTN (Hacihasanoglu & Gozum, 2011). Somewhat similar results were found 
with eight weekly educational sessions for hypertensive nursing home residents who 
demonstrated significant improvement in BP and self-care behaviors including exercise; 
however, not with medication adherence (Park et al., 2012). Furthermore, a study assessing 
weekly educational sessions for 12 weeks found improvement in HTN knowledge and self-care 
scores of participants although with no significant reduction of BP (Ozoemena et al., 2019). Kilic 
and colleagues (2015) found a 10 mm Hg reduction in SBP and increased self-efficacy after 6 in-
home educational sessions. By the same token, Darrat and colleagues (2018) reported significant 
improvement in BP, lifestyle and HTN knowledge after only one 3-hour group educational 
session with a multidisciplinary team for participants screened with a BP greater than 140/90 mm 
Hg. Moreover, at a 4-month post-intervention evaluation, participants had a significant reduction 
in weight of 7kgs and a reduction in SBP and DBP of 17 mm Hg and 7 mm Hg (Darrat et al., 
2018).  
Other studies have assessed the effect of education interventions along with pamphlets, 
booklets and/or follow up on BP and lifestyle modifications. Golshahi and colleagues (2015) 
compared the effects of interventions in 4 groups: 8 education sessions, 4 pamphlets, 8 short 
message system (SMS) messages/text messages or usual care. All groups besides the usual care 
for HTN had improved SBP but the 8 educational sessions were found to improve both vegetable 
intake, DBP, and medication adherence (Golshahi et al., 2015). Likewise, Khorsandi and 
colleagues (2017) compared 2 educational sessions to pamphlets. The educational sessions 
improved HTN knowledge, decreased perceived barriers to control and increased perceived 
benefits of control compared to the pamphlet’s sessions (Khorsandi et al., 2017). In addition, a 




colleagues (2019) utilized 4 educational sessions with a goal worksheet to improve HTN self-
care. Participants increased their physical activity and weight management compared to no 
education or goal worksheet (Farazian et al., 2019). Additionally, Khosravizade and colleagues 
(2015) found similar results with 4 education sessions and use of a self-care card and booklet. 
Participants experienced an improvement in their weight management, diet, sodium 
consumption, and BP (Khosravizade et al., 2015). Moreover, Daniali and colleagues (2017) 
combined 6 education sessions, a specific action plan for participants, and SMS follow up 2 
times a week. Participants had increased physical activity, self-efficacy, improved nutrition, and 
BP (Daniali et al., 2017). They found the nutrition effects dissipated with time and were not 
statistically significant at 6 months follow up. Lastly, Ghezeljah and colleagues (2018) compared 
the effects of 1 individual educational session with or without telephone or social networking 
follow up for 6 weeks. Self-management behaviors improved for all education groups, the self-
management behavior improvement was significantly higher in the education groups that had 
telephone or social networking follow ups (Ghezeljah et al., 2018).  
Education interventions have proven effective in helping patients to adjust their lifestyle 
and adopt measures that may lower their BP. This can be completed through both group or 
individual education sessions, telephone and text follow ups, and development of individualized 
goals or action plans.  
Hypertension Self-Care Profile 
The project will utilize the Hypertension Self-Care Profile (HBP- SCP) Behavior 
questionnaire to assess the self-care behaviors of the participants (Appendix B). The HBP-SCP 
was developed by researchers to cover multiple aspects of self-care pertinent to HTN and was 




(Han et al., 2014). The HBP-SCP can be utilized to assess the behavior, motivation, and self-
efficacy of patients with HTN (Han et al., 2015). The questionnaire consists of 60 questions; 20 
questions for each area of interest of behavior, motivation and self-efficacy. The 20-question 
behavior, motivation and self-efficacy profiles can be used in conjunction with each other or 
separately (Han et al., 2015). The HBP-SCP was written at the 6th-grade reading level and has 
high reliability with Cronbach’s alpha coefficients of 0.83 for the Behavior Scale, 0.93 for the 
Motivation Scale, and 0.91 for the Self-Efficacy Scale well above the acceptable level of 0.70 
(Han et al., 2015). Item-total correlations for the HBP-SCP ranged from 0.20-0.74 above the 
acceptable level of 0.15 (Han et al., 2015). The HBP-SCP had test-retest reliability completed in 
an Asian population in Singapore with intraclass correlation coefficients of 0.857-0.931 (Koh et 
al., 2016). The HBP-SCP Behavior Scale utilizes 4 response options: rarely/never =1, sometimes 
= 2, frequently = 3, and always = 4 (Ademe et al., 2019). The scale can differentiate between 
patients that have controlled BP and those without controlled BP (Han et al., 2015). 
Summary 
         Available data have consistently demonstrated dietary changes involving the DASH diet, 
sodium restriction and potassium supplementation are effective in lowering BP in patients with 
hypertension. Additionally, lifestyle modifications involving increased physical activity, weight 
loss, and alcohol reduction decrease BP.  Smoking cessation is considered an important 
component of care for patients with HTN since both put the patient at risk of CVD. Patients 
incorporating a combination of dietary changes as well as an increase in physical activity and 
weight loss increased the cumulative effect lifestyle changes can have on BP reduction. 
Likewise, educational interventions improve patient’s understanding and self-care of HTN, in 




primary care provider can affect BP and adherence to medication regimen as well as lifestyle 
modifications. In addition, follow up with patients through telephone or SMS after educational 


























This chapter presents an overview of the theoretical model that was utilized for this 
Doctor of Nursing Practice (DNP) project and how the model was used to guide the 
implementation of the educational intervention to promote change in patient behavior.  
Health Decision Model 
The conceptual model that was utilized for this DNP project was the Health Decision 
Model. The Health Decision Model is based on the Health Belief Model but also incorporates 
patient preferences, decision analysis, and the behavioral theory (Eraker et al., 1985). This model 
is utilized to assess factors that affect the likelihood a patient will participate in a recommended 
health action and guide providers in improving patient compliance with treatment plans (Eraker 
et al., 1984). The model is comprised of a patient’s health beliefs that are impacted by their 
individual patient preferences, prior experience with and knowledge of the disease, social 
interactions, and sociodemographic factors (Bellamy, 2004). This model was used as a guide for 
how an educational intervention can impact the patient’s adoption of and compliance with 
lifestyle modifications for hypertension (HTN).  
Health Beliefs 
     The patient’s general and specific health beliefs or attitudes regarding their health 
contribute to the patient’s decision to follow a treatment plan (Eraker et al., 1984). These beliefs 
are comprised of their concern for general health, willingness to accept medical direction, 
satisfaction with medical encounters, and their perceived susceptibility and severity of a health 
condition (Eraker et al., 1984). A patient’s health beliefs can be assessed for inaccuracies and 




through educating about HTN severity, risks, and treatment through lifestyle changes, as well as 
providing individual education and telephone follow-up to the patient to improve their medical 
encounters for HTN. In addition, improving a patient’s willingness to accept medical direction 
through development of an individualized action plan which considered their preferences for 
lifestyle modifications was also an aim of this DNP project.  
Patient Preferences 
     Shared decision making is becoming the preferred communication method for many 
health organizations regarding the selection of treatment options with patients (Smith et al., 
2016). Shared decision making is comprised of assessing and including patient preferences when 
discussing all treatment options for a disease process (Smith et al., 2016). Taking patient 
preferences into account is very important when discussing treatment plans involving lifestyle 
modifications. Smith and colleagues (2016) report 71.8% of patients feel that shared decision 
making is very beneficial when it comes to incorporating lifestyle modifications. This DNP 
project included patient preferences through the development of an individualized action plan of 
how the patient can implement lifestyle modifications for HTN. Helping patients develop their 
own individualized, clear goals for behavior change can promote the likelihood of success 
towards improvement in lifestyle (Bardach, & Schoenberg, 2018). 
Knowledge 
     A patient’s knowledge of HTN is an important factor in adherence to treatment regimens. 
Jankowska-Polanska and colleagues (2016) report 63% of patients had low levels of knowledge 
regarding HTN definition, treatment, and complications. Lower levels of knowledge were 
associated with lower adherence to treatment regimens with adherence increasing with higher 




patient knowledge of HTN through an educational intervention. The education session included 
improving knowledge of HTN, lifestyle modifications that have proven effective in lowering 
blood pressure (BP), home-monitoring of BP, and medication adherence.   
Social Interactions 
     The social support a patient receives is a significant factor in a patient’s self-efficacy for 
both diet and exercise (Chair et al., 2015). The support and interactions of not only companions, 
family, and friends but also from health-care professionals may help patients overcome the 
barriers to lifestyle change (Chair et al., 2015). Primary care providers who have positive 
relationships with their patients can influence health behavior change in their patient’s lives 
(Bardach, & Schoenberg, 2018). This DNP project will promote positive social interactions with 
the health-care provider by providing an individualized educational session with 2 follow-up 
phone calls to provide support and answer questions. The patient will have an in-person follow-
up visit 3 months after the educational session to assess the patient’s improvement and progress 
towards their goals for lifestyle modification. This DNP project provided multiple points of 
interaction between the patient and provider to support the patient’s adoption of lifestyle changes 
and give opportunities to provide feedback on perceived barriers to change during 
implementation.  
Summary 
     The Health Decision Model can guide the healthcare provider in improving patient 
compliance with a treatment plan. The Health Decision Model addresses multiple factors that 
help determine a patient’s willingness to follow a proposed course of action to treat illness. The 
model will serve as a guide to improve patient compliance with lifestyle modifications for HTN. 




consider patient preferences in development of a goal-oriented action plan, increase social 
interaction with the provider to encourage adoption of the action plan/lifestyle modifications in 







































 This section contains an assessment of the need for this Doctor of Nursing Practice 
(DNP) project. What will follow is the needs assessment, the project plan, and the evaluation 
plan. 
Needs Assessment 
     Current literature shows that self-care measures are beneficial in lowering a patient’s 
blood pressure (BP). Clinical practice guidelines recommend that lifestyle modifications be 
considered first-line treatment in patients with prehypertension and stage 1 hypertension (HTN), 
as well as used in conjunction with medication in patients with stage 2 HTN (Whelton et al., 
2018). Currently, the clinic where the DNP project author works does not have an educational 
intervention to aid patients in understanding their diagnosis, lifestyle modifications, and 
treatment plans. Based on current clinical practice guidelines and research, there is a need for 
educational materials and structured education plans for patients at this clinic with diagnosed 
HTN to ensure the adoption of lifestyle modifications as recommended for management. 
Project Plan 
Setting 
 The DNP project took place in a family practice clinic. The practice clinic is in 
Henderson, NV. The clinic has three providers: a physician and 2 nurse practitioners. The 
education session took place individually in one of the patient rooms of the clinic.  
Population of Interest 
     The population of interest was non-pregnant English-speaking adults at the clinic ages 




antihypertensive medications, and under the care of one of the healthcare providers at the clinic 
for treatment of their HTN within the last 12 months of the project implementation. 
Measures, Instruments, and Activities  
This DNP project used a convenience sampling for recruitment. Flyers (Appendix K) 
were placed in the patient rooms and waiting room one month prior to the start of the quality 
improvement project at the family practice clinic. Patients willing to participate in the project left 
their name and contact information with office staff. Willing participants were screened to make 
sure they met the inclusion criteria.  
This DNP project utilized a demographic questionnaire, certain biometric readings, and 
the HBP-SCP Behavior scale to assess the self-care measures of the participants. Before the 
educational intervention, participants completed an informed consent form (Appendix D) and 
filled out the demographic questionnaire to assess their age, gender, and education level 
(Appendix E). The participants had their height, weight, BMI, and BP measured by the DNP 
author at the first visit with the educational intervention. Participants were instructed to avoid 
smoking, exercise, caffeine, and alcohol 30 minutes before their BP measurements. The DNP 
project utilized the 20 question HBP-SCP Behavior Scale before the educational intervention to 
assess the baseline self-care behaviors of participants.  
The participants then participated in an individual education session for 30-60 minutes 
regarding HTN definitions, risks of HTN, and lifestyle modifications/self-care behaviors for 
HTN (Appendix F) with the DNP author. The participants then completed an action plan 
(Appendix H) to develop individualized goals to improve their self-care of HTN over the next 3 
months. The participants were given a handout (Appendix G) that summarizes the information 




Blood Pressure With DASH”, (Appendix I) from the National Heart, Lung, and Blood Institute 
(NIH). The participants received a follow-up phone call at 1 month and 2 months from the DNP 
author following the educational session to assess their progress toward their goals and answer 
questions as needed for the participant regarding their lifestyle changes, medications, or BP 
readings.  
The participants underwent an in-person or telephone follow-up visit with the DNP 
author 3 months after the educational session. If in-person participant’s weight, BMI, BP was 
reassessed at the follow-up visit. All the 3-month participants repeated the HBP-SCP Behavior 
scale at the in-person or telephone follow-up. The participants were instructed to bring their 
previously developed action plan with them to reassess their goals and adjust or develop new 
goals as needed with a new action plan document (Appendix H). 
Timeline 
 The project consisted of 3 phases: pre-implementation, implementation, and post-
implementation. The pre-implementation phase included the DNP proposal defense, obtaining 
IRB approval and flyers displayed for recruitment. The implementation phase included screening 
participants for inclusion, the education session with accompanying questionnaires and biometric 
readings, 2 phone follow-ups and the 3-month post education in-person or telephone follow up. 
The post implementation phase included evaluation and analysis of the data collected. Table 1 
provides a detailed outline of the timeframe for necessary tasks (Appendix J). 
Key Stakeholders 
     Key stakeholders for this project were the healthcare providers for the clinic who treat 




from better control in their BP and improved lifestyle choices that would impact the patient’s 
overall health status.  
Project Tasks and Personnel 
     The personnel consisted of the DNP author, and staff of the family practice clinic. The 
office staff collected the names and contact information of those willing to participate in the 
quality improvement project. The DNP author created, implemented, and conducted the 
education sessions and completed the telephone and in-person follow-ups.  
Cost-Benefit Analysis 
     The cost of healthcare for patients with HTN is higher compared to non-hypertensive 
patients. It is estimated that patients with HTN spend $2,000 more annually each year on 
healthcare costs, with the average total national cost for HTN care reaching $131 billion each 
year (Kirkland et al., 2018). A patient with HTN can expect to spend 3 times as much on 
prescription medications and 2 times on outpatient costs a year (Kirkland et al., 2018). The 
financial burden of HTN for society, patients and their families warrant effective measures to 
help improve BP control and its associated costs. Education and preventive services are cost-
effective ways to improve the financial burden of chronic diseases. The educational intervention 
had minimal costs associated with its implementation. The cost incurred included copies of the 
questionnaires, educational handouts, and action plan that were provided to the participants. The 
educational intervention and follow up occurred at the clinic of the participant’s primary care 
provider and did not incur added costs to the participant or provider since the education was be 
completed by the DNP author. The clinic allowed the use of their current equipment as needed 




society of improved BP control outweighs the minimal cost of implementing an education plan 
for HTN management. 
Resources and Supports 
 The DNP project received support through the family practice clinic that allowed the use 
of the facilities and equipment for the implementation phase. The minimal costs of printing the 
education handouts and action plans was provided by the DNP author.  
Risks and Threats 
 Risks to the project included inability to obtain participants for the study as well as lack 
of follow-up from participants that completed the education session that would affect the pre- 
and post- intervention analysis. The rate of loss to follow-up for questionnaires can be high with 
mail in questionnaires having return rates of 20-30% and a computer-based questionnaire having 
a retest rate of 44.4% (Koh et al., 2016). The project utilized phone follow-up calls and an in-
person follow-up to try to improve the retest rate.  
Institutional Review Board Approval 
 A letter of exclusion was received through the University of Nevada, Las Vegas 
Institutional Review Board (IRB) to complete this project (Appendix L). Informed consent was 
obtained from the participants in the implementation phase of the project.  
Evaluation Plan 
This DNP project utilized a pre- and post-intervention model to evaluate the project. The 
participant’s biometric readings and HBP-SCP scores were compared pre- and post-education 
intervention to assess the effectiveness of the intervention to improve self-care behaviors of the 
participants and its possible effect on participant’s BP and weight. The total score on the HBP-




action plan implementation.  The paired t-test was utilized to compare the difference in self-care 







This section contains an overview of the implementation of the Doctor of Nursing 
Practice (DNP) project, statistical results, discussion, and future implications for practice and 
research.  
Implementation 
 The flyers for the DNP project were displayed in the foyer, hallway, and patient rooms of 
the designated family practice clinic after receiving a letter of exclusion from the University of 
Nevada, Las Vegas IRB (Appendix L). In addition, with the encouragement of the owner of the 
clinic, patient’s that met the inclusion criteria were also contacted by telephone by the DNP 
project author to notify them of the quality improvement project and to provide them with an 
opportunity to choose to participate. A total of 50 patients who met the inclusion criteria showed 
interest in the quality improvement project. The inclusion criteria was non-pregnant English-
speaking adults at the clinic ages 35-55 years old who had been diagnosed with essential HTN, 
were currently on one or more antihypertensive medications, and under the care of one of the 
healthcare providers at the clinic for treatment of their HTN within the last 12 months of the 
project implementation. Out of the 50 interested patients, 45 scheduled appointments for the 
education session with 8 cancellations or no shows; 37 participants completed the education 
session. 
The DNP project author reached out to the 37 participants for telephone follow-up at 4 
weeks and 8 weeks and was able to complete at least one telephone follow-up with 32 (86%) 
participants.  The DNP project author also reached out to all 37 participants at week 11 to 




total of three participants had to cancel or did not show for their follow-up appointment; a total 
of 21 (57%) participants completed a portion of the 12-week follow-up.  
While completing the in-person follow-ups, the DNP project author had a potential 
exposure to SARS-CoV-2, which was unrelated to the project. As a result, it was decided to stop 
the in-person follow-ups of the participants and complete the remainder of the follow-ups via 
telephone. A total of 10 participants completed the in-person follow-up with repeat biometric 
readings and the HBP-SCP questionnaire before switching to telephone follow-ups. The 
remaining 11 participants completed a telephone follow-up with repeat of the HBP-SCP 
questionnaire via telephone for a total of 21 participants completing a post intervention HBP-
SCP.  
Demographic Statistical Results 
 SPSS version 26 was used for the demographic and descriptive analysis. Of the 37 
participants that completed the education session, 43.2% were females and 56.8% were males 
with 18.9% in the 35 to 44-year-old age group and 81.1% in the 45 to 55-year-old age group. 
The rates for age and gender of those completing the 12-week follow-up session was 47.6% 
female and 52.3% male and 23.8 % in the age group 35 to 44-year-old and 76.2% in the age 
group 45 to 55-year-old. Table 1 displays the demographic table for gender of the initial and 
follow-up participants, whereas, Table 2 displays the demographic table for age range of the 









Gender of Participants 




n % n % n % 
Female 16 43.2 10 47.6 5 50 
Male 21 56.8 11 52.3 5 50 




Age of Participants 




n % n % n % 
35-44 7 18.9 5 23.8 2 20 
45-55 30 81.1 16 76.2 8 80 
Total 37 100 21 100 10 100 
 
 
The education level of the 37 participants was: 3% high school graduation or equivalent, 
16.2% some college, 27.0% an associate degree, 29.7% a bachelor’s degree, and 18.9% a 
master’s degree. The education level of the 21 follow-up participants varied from the initial 
participant group. Of the 21 participants who completed the 12 week in-person or telephone 
follow- up 9.5% had some college education, 23.8% had an associate degree, 42.9% had a 
bachelor’s degree, and 23.8% had a master’s degree. Of the participants who had a higher level 
of education, they were 3.6 times more likely to complete the 12-week follow-up session (p 






Education Level of Participants 










3 8.1 0 0 0 0 
Some 
College 
6 16.2 2 9.5 1 10 
Associate 
Degree 
10 27.0 5 23.8 0 0 
Bachelor’s 
degree 
11 29.7 9 42.9 6 60 
Master’s 
Degree 
7 18.9 5 23.8 3 30 
Total 37 100 21 100 10 100 
       
  
Of the initial participants, 0% of those who graduated high school, 33% of those with 
some college education, 50% of those with an associate degree, 82% of those with a Bachelor’s 
degree, and 71% of those with a Master’s degree completed follow-up. 
Descriptive Statistical Results  
Of the 21 participants who completed the 12-week post intervention HBP-SCP 
questionnaire, the initial mean score was 53.3. The scores on the questionnaire can range from 20 
to 80 with a higher score indicating better self-care of hypertension (HTN). For those 
participants who completed the post-intervention HBP-SCP questionnaire (N = 21) there was a 
mean increase in the total HBP-SCP score of 6.24, which was statistically significant (p =.001). 






Comparison of Pre and Post HBP-SCP scores 
 
Paired Differences 
t df p M SD SE 
95% Confidence  
LL UL  
HBP-SCP Pre – 
HBP-SCP Post 
-6.23810 7.37499 1.60935 -9.59515 -2.88104 -3.876 20 .001 
 
 
 When assessing the pre-intervention and post-intervention effect on the scores of each 
individual question from the HBP-SCP questionnaire, questions 1 through 18 all showed an 
increase in the scores.  The change in pre to post-intervention scores was statistically significant 
in 7 of the 20 questions: question 1 (p =.008), question 3 (p =.024), question 6 (p = .038), 
question 9 (p =.029), question 11 (p =.002), question 14 (p =.047), and question 18 (p =.024). 
Moreover, questions 2 and 4 neared statistical significance (p =.071). 
 Of the 10 participants who completed the 12-week follow-up biometric readings 5 
participants were female and 5 participants were male. The initial mean body mass index (BMI) 
was in the obese category at a value of 33.27. For the 10 participants who completed the 12 week 
in-person follow-up, there was a mean increase in weight (0.78 pounds) and a mean increase in 
BMI (0.15). There were only 3 participants that lost weight during the intervention, all 3 were 
male participants who had improvement in their post-intervention HBP-SCP score. The 
remaining 2 males did not lose weight and did not have improvement in their HBP-SCP score. 
The mean pre-intervention systolic blood pressure (SBP) in the 10 in-person follow-up 
participants was 136.25 mm Hg which decreased to a mean of 131.40 mm Hg at post-
intervention for a mean decrease in the SBP of 4.85 mm Hg. When assessing the change in the 




while the females had a mean decrease of 7.2 mm Hg. The mean pre-intervention diastolic blood 
pressure (DBP) was 87.75 mm Hg which reduced to 84.45 mm Hg for a mean decrease of 3.3 
mm Hg. There was also a difference in the mean decrease of the DBP based on gender. The 
males had a mean decrease in the DBP of 4 mm Hg and the females had a mean decrease of 2.6 
mm Hg. Table 5 displays the pre- and post-intervention biometric readings and HBP-SCP scores 





























































































































47 57 10 125 131.5 6.5 83 83.5 0.5 35.5 34.5 -1 
45-
55 
F Bach. 58 67 9 118.5 108.5 -10 80 71.5 -8.5 23.3 24.1 0.8 
45-
55 
F Mast. 56 50 -6 119 123.5 4.5 86 87.5 1.5 35.2 35.8 0.6 
45-
55 
F Mast. 54 63 9 138 122 -16 79 69 -10 61.5 62.3 0.8 
45-
55 
F Bach. 57 62 5 182 165 -17 95 97 2 29.8 29.8 0 
45-
55 
M Bach. 49 53 4 140 119.5 -20.5 93 81 -12 25.1 24.4 -0.7 
45-
55 
M Bach. 45 47 2 140.5 143.5 3.5 93.5 95.5 2 34.7 34.4 -0.3 
45-
55 
M Bach. 71 70 -1 145 139.5 -5.5 95 84 -11 25.5 26 0.5 
45-
55 








 Most of the participants for this DNP project were male (56.8%); this is consistent with 
the current estimated rates of those who suffer from HTN. According to Whelton and colleagues 
(2018), HTN occurs more in males (48%) versus females (43%). It is assumed that more males 
participated in this project since they have higher rates of HTN. The follow-up rates stayed 
consistent with the initial rates; males (52.3%) and females (47.6%) and there was no correlation 
between gender and the likelihood of completing follow-up. 
Most of the initial participants were in the age group 45-55 (81.1%). It would be expected 
that more participants would fall in this age group since the rate of HTN increases with age. 
According to Whelton and colleagues (2016), 19% of those aged 20-44; whereas, 30% of those 
aged 45-55 are diagnosed with HTN. Furthermore, males aged 45-54 suffer from having HTN 
more than females; 50% and 44% respectively (Whelton et al., 2016). With this said, it is 
assumed the higher participation rate for those aged 45-55 is partly due to the increased rate of 
HTN among this age group, but also by the patient population served in the setting where the 
DNP project took place. Most of the patient population served in the family practice clinic is 
older adults; therefore, justifying the higher rate of participants in the 45-55 age group. To add, 
the rates of the age groups for follow-up stayed consistent at 76.2% for the 45-55 age group and 
23.8% for the 35-44 age group. Generally speaking, there was no correlation between the 
likelihood of follow-up and the age of the participant.  
Overall, the participants had higher educational levels than the general United States 
(U.S.) adult population. According to the United States Census Bureau (2021), the most recent 




some college (15.6%), associate degree (10.4%), bachelor’s degree (22.6%), and master’s degree 
(10%). In comparison, the rates of educational achievement among the 37 initial participants 
were much higher: high school graduation or equivalent (8.1%), some college (16.2%), associate 
degree (27%), bachelor’s degree (29.7%), and master’s degree (18.9%). According to Gharaibeh 
and colleagues (2020), education and income level have been linked to a patient’s willingness to 
engage in clinical trials which may partly explain why the participants of this DNP project had 
higher educational levels. Furthermore, the participants with higher educational levels were 3.6 
times more likely to complete the follow-up. This further correlation to education level and 
completion of the project may also explain why they were willing to participate initially.  
Generally speaking, the results of this project indicate an increase in self-care measures 
of patients with HTN. The overall HBP-SCP questionnaire scores showed a statistically 
significant increase in the post-intervention compared to the pre-intervention of the 21 follow-up 
participants. The project’s interventions of providing an educational session with completion of a 
patient action plan for self-care measures of HTN, in addition to a 4-week, 8-week and 12-week 
follow-up was effective in increasing the participant’s implementation of self-care measures. 
This corresponds with the recommendation from the clinical practice guidelines that a 
combination of interventions such as goal setting, follow-up, feedback, and promotion of self-
sufficiency are the most effective when combined (Whelton et al., 2018).  
Hypertension Self-Care Profile 
The HBP-SCP questionnaire covers several items related to self-care measures for HTN 
(see Appendix B). The items most significantly improved from this project include physical 
activity, sodium intake, fat intake, fruit/vegetable intake, checking home blood pressure, and 




Physical Activity. Question 1 asks how often participants take part in regular physical 
activity. It is interesting that there was significant improvement in the physical activity of 
participants since this was not discussed in detail with them. Participants were told that physical 
activity is part of self-care measures for HTN but were instructed to contact their PCP and/or 
cardiologist for approval before beginning exercise. It appears that although not emphasized in 
the education as participants improved their dietary habits for HTN and other self-care measures 
they chose to increase their physical activity as well.  
Diet. Questions 2-5 focus on dietary sodium intake. Question 3 asks about how often 
participants replace high-salt foods with lower salt options. This question had a significant 
improvement in the post intervention score. Questions 2, 4, and 5 also improved with 2 and 4 
nearing significant improvement. Questions 6-10 focus on fat intake in the diet. Question 6 asks 
how often they eat less foods high in saturated and trans-fat while question 9 asks how often they 
replace high-fat foods with lower-fat options, both had a significant improvement in the post 
intervention scores. The other questions 7, 8 and 10 also showed improvement. Question 11 asks 
about how often they eat 5 or more servings of fruits and vegetables a day. There was a 
significant increase in the post intervention scores. Overall, participants dietary changes focused 
on replacing high sodium and fat foods with lower sodium and fat options while increasing the 
amount of fruits and vegetables in their diet. The questions that asked about specific mg and 
gram amounts in the diet had an improvement but not significant. It appears that most 
participants were willing to make changes in replacing or adding in foods for HTN versus 
tracking specific amounts of the fat and sodium in their diet.  
Alcohol and Tobacco Use. Question 12 asks how often participants practice moderation 




moderation pre-intervention. In the post intervention 20 of the 21 reported as always or 
frequently practicing moderation but this was not statistically significant. Question 13 asks how 
often they practice non-smoking, there was improvement in the post-intervention scores but 
again not statistically significant. This may be in part since 20 of the 21 participants reported as 
always practicing non-smoking and only 1 reporting rarely/never practicing non-smoking pre-
intervention. This one participant that smoked reported as frequently practicing non-smoking at 
post-intervention.  
Home BP Monitoring and Medication Adherence. Question 14 asks how often 
participants check their BP at home. There was a significant increase in the post-intervention 
scores. Participants were also more likely to bring in a copy of their home BP measurements to 
their PCP to be a part of the discussion of their BP control and management. Questions 15 and 
16 focus on aspects of medication adherence. Question 15 asks how often they forget to take 
their BP medication and 16 asks how often they forget to fill their prescription. The pre-
intervention scores were high for both questions with 1 participant reporting as frequently, 2 
reporting as sometimes and 18 reporting as rarely/never. Post intervention the number of 
participants reporting as rarely/never forgetting was 19 with 2 reporting as sometimes. Similar 
results are seen with question 16, pre-intervention 2 participants reported as sometimes 
forgetting to fill their prescription and 19 reported as rarely/never. Post-intervention 1 participant 
reported as sometimes forgetting and 20 reported as rarely/never forgetting. Although there was 
improvement in both questions it was not significant, this is most likely in part because the pre-
intervention scores were already high with very little room for improvement.  
Weight management. Question 17 focuses on weight of the participants. It asks how 




and many that were overweight or obese did not know how to answer this question even if they 
were actively trying to lose weight. There was an improvement in the scores post-intervention 
which contradicts with the fact that there was an increase in the mean weight of participants of 
0.78 lbs. post-intervention. This discrepancy may be in part due to the confusing nature of this 
question to many of the participants.  
Stress Management. Question 18 and 19 focused on stress in relation to HTN. Question 
18 asks how often participants monitor for high levels of stress that could result in BP elevation. 
There was a significant increase in the number of participants that monitored for stressful 
situations, but this did not produce increases of scores in response to question 19 that focused on 
engaging in activities that relieved stress. Participants were more aware of the stressful situations 
in their life but did not engage in more stress reducing activities. This may be in part due to the 
focus of the HTN education session. Although stress/anxiety was mentioned as a potential 
contributor to increases in BP the education did not focus on activities to lower stress levels. The 
increased awareness of stressful situations may also be in part due to the SARS-CoV-2 
pandemic.  
 Follow-up. The final question, question 20, focused on how often participants see their 
doctor regularly. There was no change in mean of the pre-intervention and post-intervention 
scores for this question. This may be due to the timeframe of the intervention being 12 weeks. 
Most patients with HTN should follow-up with their provider every 3 months/12 weeks 
according to clinical practice guidelines (Whelton et al., 2018). The length of time the 
intervention was conducted may not have been enough time for any change in frequency of 





There was a reduction in the mean SBP (M= 4.85 mm Hg) and DBP (M= 3.3 mm Hg) for 
the 10 participants that the DNP author was able to obtain repeat measurements for. The female 
participants had a greater reduction in their SBP (7.2 mm Hg) than the male participants (2.4 mm 
Hg). This may be attributed to the fact that the female participants had a greater mean 
improvement in their post-intervention HBP-SCP scores (4.8) compared to the male participants 
(3). The ability to assess the full impact of the quality improvement project on BP was affected 
by the inability to obtain repeat measurements on all 21 follow up participants. The small sample 
size of 10 participants prevented the ability to run statistical analysis. The DNP author would 
have been interested in knowing the full effect on BP for all 21 participants since their HBP-SCP 
scores were statistically significant. Furthermore, the mean improvement in the overall post-
intervention HBP-SCP score was lower in the 10 in-person follow-up participants (3.9) 
compared to all 21 participants (6.24). 
The weight and BMI of the 10 participants with repeat measurements increased slightly 
by 0.78 lbs. and the BMI by 0.15. Even though the participants scored higher on their post-
intervention HBP-SCP scores this did not translate into decreased weight for the entire group. 
Only 3 of the participants lost weight during the intervention, all 3 of which were male 
participants. This may be in part that the process of weighing the participants was not as 
controlled as the BP measurements. The scale for weighing participants is in the hall of the 
family practice clinic. Due to this the participants would need to be weighed with their clothes 
on. The participants were not instructed to wear the same clothes both days and this may 
influence the weight of the participants. When the project started it was warm weather and many 
participants were wearing lighter clothing compared to when the project completed in winter and 




lack in weight change with the intervention but most likely would not explain fully why the 
weight as a group did not decrease despite making healthier food choices. Williams and 
colleagues (2015) found that there are differences in weight loss related to gender. Although both 
males and females can lose weight with diet and exercise these interventions produce greater 
weight loss in males (Williams et al., 2015). This may partly explain why only men lost weight 
during the 12-week time frame.  
Limitations  
There were several limitations with the quality improvement project. A limitation of the 
project was the use of convenience sampling. The convenience sampling may not reach all 
potential participants at the clinic and may over inflate the effect of the education. Patients who 
are more willing to adjust their self-care measures for HTN may have been more interested in 
participating. Since the participants in this project also had higher education rates than the 
average for U.S. adults, this may affect the generalizability to patients with a lower education 
level. This project also did not question patients regarding their race or ethnicity and their 
socioeconomic status (SES). This affected the ability of this project to assess generalizability to 
patients based on their race or ethnicity and SES.  
 The project was greatly impacted by the SARS-CoV-2 pandemic. Due to the pandemic 
during implementation phase, the participants were limited to the age ranges of 35-44 and 45-55. 
This may impact the generalizability to older age groups. The pandemic also affected the ability 
for in-person follow-up. Due to exposure to SARS-Cov-2 of the DNP author, the project was 
only able to obtain repeat biometric readings on 10 of the 21 follow up participants. As a result, 
this impacted the ability to fully assess the effect the education may have had on weight, BMI, 




week period, one of them being hospitalized due to the illness. They all 3 reported that the illness 
affected their ability to fully implement the self-care measures as they had intended.  
Post-Implementation Insights 
 Through implementation of this project and education session several insights were 
gained including further support with implementing future projects. While completing the 
education sessions, the DNP project author observed many of the participants were aware of 
most of the self-care measures to help HTN but were unaware of how to implement them 
correctly. For example, many participants knew that sodium reduction in the diet would help 
lower BP; however, they were lacking key components to implement this reduction in their diet. 
In addition, the DNP project author observed most participants did not know what the 
recommended mg/day of sodium intake is for HTN, were not aware of common dietary sources 
of sodium, and very few already tracked their sodium intake. Of the 37 initial participants 32.5% 
frequently or always checked for sodium content and of the 21 follow-up participants 38.1% of 
them frequently or always checked sodium content prior to the education sessions which 
increased to 61.9% post-intervention. The DNP project author also observed  most of the 
participants already had a BP cuff at home for taking home readings but were unaware of 
recommendations on how often to check the BP, accurate steps for checking at home, and most 
rarely recorded their readings to provide to their primary care provider (PCP) at regular follow- 
up appointments. Bilal and colleagues (2016) conducted a study which also supports these 
observations. They found that although 69.1% of participants claimed to check their BP 
frequently, when assessed further only 27.8% of participants checked it at least once a week per 
current clinical practice guidelines (Bilal et al., 2016). Healthcare providers need to ensure that 




care measures. Unfortunately, healthcare providers may assume that patients are already aware 
of HTN self-care measures when they are in fact lacking important details preventing them from 
incorporating HTN self-care measures appropriately.  
Although the education sessions and follow-ups for this DNP project were set up 
separately from regularly scheduled appointments the interventions should be incorporated 
within regularly scheduled office or telemedicine visits for sustainability purposes. A 
considerable amount of time was spent by the DNP project author on the phone trying to 
schedule the education sessions and 12-week follow-ups, as well as trying to get the participants 
by phone at the 4-8-week follow-ups. The amount of time spent on the phone by the DNP project 
author would be unsustainable for a provider and clinic if this is not incorporated into regular 
billable services. Education is an important role of healthcare providers and is reimbursable by 
insurance companies and can be billed based on the amount of time spent with the patient or 
family providing education and other services that accompany a patient office visit (AMA, 
2019). Healthcare providers should consider completing the education session during a 
scheduled office visit, and then schedule a 4 and 8-week follow-up with patients through a 
telemedicine or scheduled telephone visit if allowed by insurance and complete the 12- week 
follow-up scheduled in the office. Furthermore, healthcare providers should continue use of the 
patient action plan and BP monitoring sheets at regularly scheduled office visits to continue 
reinforcing goals, as well as adoption of HTN self-care measures. In the end, the aforementioned 
may be more sustainable to implement with future quality improvement projects.  
Clinical Implications for Practice, Health Policy, & Education 
 This DNP project has implications for healthcare providers and entities on how to 




self-care goals with frequent follow-ups does impact the patient’s adoption of self-care measures 
for HTN. Therefore, this should be routine practice for healthcare providers who care for patients 
with HTN. Current clinical practice guidelines recommend patients with HTN should receive 
regular monthly to every 3-6-month follow-up visits (Whelton et al., 2017). During these regular 
visits is when healthcare providers should take the time with patients to provide HTN education, 
reinforce HTN self-care measures, and evaluate goals towards adoption of these measures. By 
implementing this project’s interventions, a healthcare provider can improve a patient’s HTN 
self-care measures which may potentially impact their overall BP control and risk of morbidity. 
According to Whelton and colleagues (2017), modest sustained lifestyle changes have the 
potential to significantly reduce the risk of morbidity and mortality from cardiovascular disease 
and should be a primary focus for patients by their PCP. Accordingly, healthcare 
agencies/entities should encourage and allow healthcare providers who manage HTN to have the 
resources and time to educate their patients on this chronic disease as well as self-care measures. 
Implications for Future Projects and/or Research 
 Future projects or research could consider offering the education virtually via online 
platforms instead of in person. There is the potential that more patients may participate if the 
education was completed virtually due to potential decrease in time (travel time), cost for the 
patient to get to a clinic, and currently at this time due to concern for risk of exposure to SARS-
CoV-2. Rush and colleagues (2018) found that virtual education was as beneficial, and in some 
instances, more beneficial than in-person education for chronic diseases such as diabetes, chronic 
obstructive pulmonary disease, inflammatory bowel disease, and heart failure. These conditions, 




their diagnosis. To that end, if virtual education was beneficial in these other chronic conditions 
it may be beneficial as well for HTN education.  
Implementation of this DNP project with older adults could be utilized to further assess 
the generalizability of the intervention. Future projects could also assess the potential impact on 
weight, BMI, and BP with this education intervention by completing the 12-week follow-up in-
person for all participants for repeat biometric readings. Due to the short follow-up time frame in 
this project and the chronic nature of HTN, it may also be beneficial to assess the impact this 
intervention has on self-care and biometric readings for a timeframe longer than 12 weeks.  
 Future research should also assess for measures that could increase involvement of 
patients with lower education levels in health education interventions and follow-up. This is 
important to address since patients with a higher education level tend to already have higher self-
care measures of HTN (Ademe et al., 2019) and a better understanding of HTN (Bilal et al., 
2016). There is also a correlation between education levels and a patient’s probability of having 
uncontrolled HTN (Lee & Park, 2017).  Decreasing this disparity would be an important step to 
controlling HTN and reducing complications for patients with lower education attainment.  
 Future research should also assess the effect this intervention may have on a participant 
depending on their socioeconomic status (SES). A lower SES is associated with a higher risk of 
HTN (Leng et al., 2015).  Patients in a lower SES have poorer dietary habits and increased rates 
of alcohol and tobacco use which can contribute to elevations in BP (Leng et al., 2015). Due to 
this, current clinical practice guidelines recommend the utilization of all lifestyle modifications 
in patients with a lower SES (Whelton et al., 2018). Special attention should be focused on the 
challenges that patients will face due to limited financial resources and accessibility to health 




demographic questionnaire. This could be included in the future to assess for the impact this 
intervention has on the self-care measures, BP, and weight of patient’s with HTN in lower SES. 
Further, the use of the HBP-SCP could help providers understand which areas of self-care pose a 
particular difficulty implementing in this population.  
 Future research should also focus on the effect this intervention may have on a participant 
depending on the participant’s race or ethnicity. This DNP project did not query participant’s 
regarding their race or ethnicity. As a result, this DNP project was unable to assess whether there 
was a difference in follow-up rates, biometric readings, or self-care measures depending on the 
race or ethnicity of the participant. Ethnic minority populations face more challenges in 
implementing recommended self-care measures due to limited access to healthy foods, exercise 
opportunities, and poor social support (Whelton et al., 2018). Interventions also need to take into 
consideration different cultural values, beliefs, and preferences (Whelton et al., 2018). Future 
research should assess if implementation of this DNP project, in particular, improves the self-
care measures of minority populations.   
Conclusion 
 HTN is a chronic condition that carries with it a high risk of morbidity and mortality and 
impacts almost 1 out of every 2 adults in the U.S. (Whelton et al., 2016). Self-care measures of 
HTN are an important part of the treatment plan for patients with HTN and should be a focus for 
providers and their patients. This quality improvement project showed that through educating 
patients on HTN and self-care measures, encouraging development of a patient action plan/goals 
for self-care measures, and following up frequently with patients on their HTN and self-care 
providers can significantly improve their patient’s lifestyle choices that affect their HTN. 




fruit/vegetable intake, monitor their home BP measurements, and monitor for levels of stress. 
Further efforts are needed to assess the full impact the quality improvement project can have on a 
patient’s weight and BP. But if the interventions are continued these sustained modest lifestyle 
changes can greatly impact the risk of morbidity and mortality of HTN for our patients (Whelton 













Design and  
Procedures  













of patients in 
Dessie Town, 
Ethiopia 
-309 participants, 58 y.o. 
mean 
-Inclusion: HTN f/u in 
last 6 months, 18 y.o. or 
older, Amharic language 
-Exclusion: Critically sick 
or cognitive impairment 
-Completed HBP-SCP, 
ASAS-R, MSPSS 




-Mean score on HBP-
SCP 37.7, 51% scored 
below the mean 
-Social support and 
agency, married, 
educated, place to 
exercise and access to 
information associated 
with improved self-care 
behaviors 
-Limitations: association 
not causation, recall 
bias, did not measure 











Assess the benefit 
of home BP 
monitoring 




Science Citation Index, 
ISI proceedings, and 
hand search 
-37 RCT’s included, 2 
reviewers 
-Trials ranged from 15-
1325 patients, follow up 
of 2-36 months 
-I squared scores, Jadad 
scores, Begg test and 
Funnel plot 




-Decrease in SBP of 2.21 
and DBP of 0.82 
-Therapeutic inertia less 




common in treatment 
groups 
-1 RCT published after 
meta-analysis showed 
reduction in SBP of 3.7 
at 6 months and 5.4 at 








Evaluate the role 
of physical 
activity in HTN 
prevention. 
-No information on 




and RCT studies 
-Increasing time spent 
on Moderate-Vigorous-
Physical activity 
protects against HTN 
development 
-Effects of aerobic 
exercise on BP 
reduction greater in 
patients with HTN, SBP 
reduced 5-8, DBP 
reduced 4-5 
-One session of 







-Long term HIIT lowers 
SBP/DBP by 4.57/2.94 









effect of daily K 
intake and Na/K 





-Searched Medline for 
RCT’s, 60 studies found, 
15 included with 1 
eventually excluded due 
to outlier 
-Inclusion- 4-week trial 
or longer, RCT with at 
least 1 control and 1 
intervention group, any 
language 
-Exclusion- medication 
use, severe illness, HIV 
or hospitalized patient’s 
- 2 reviewers, 3rd 
reviewer if needed 
- Followed Cochrane 
guidelines (PRISMA) 
- Funnel plot analysis 
- 917 patients total 
- Reduction of SBP of 
3.5 mm Hg 
- Reduction in SBP of 6.8 
in hypertensive patients 
- Effect related to Na/K 
ration reduction 
-Limitations: small study 




















overweight, 35 years or 
older, SBP 130-159, DBP 
85-99, BMI 25-40, 
sedentary, not on BP 
medications, no other 
serious comorbidities 
- Randomized to control 
diet, DASH alone or 
DASH with weight 
management measures 
- 49 participants DASH 
with WM 
- 46 participants DASH 
alone 
- 49 participants control 
diet 
-DASH with WM: lost 
8.7 kg, SBP reduced by 
16.1, DBP reduced by 
9.9 
-DASH alone: lost 0.3 kg, 
SBP reduced by 11.2, 
DBP reduced by 7.5 
- Control group: gained 
0.9 kg 









Examine effect of 
education, home 
self-monitoring, 
and SMS on self-
care behavior, 
weight and BP on 
women with 
obesity and HTN 
-146 participants 
-Inclusion criteria: BP 
greater than or equal to 
140/90, medication for 
HTN, BMI greater than 
or equal to 25, 30-65 
y.o., inability to walk, no 
serious diseases 
-6 Weeks of weekly 
education sessions, 






intake but decreased 
again by 6-month f/u 
-Decrease in SBP of 7 in 
the intervention group 
-No weight change  
-Limitations: self-






-Utilized scale of self-
efficacy, weight, BP, 
nutrition, activity, and 
self-efficacy 
-Shapiro, Wilcoxon test, 
means, t-test, chi 
squared, ANCOVA, 






Assess the impact 





and BP control 
-Participants from 
community screening 
with BP >140/90, 40 
years or older, 
proficiency in English 
-Excluded unable to 
measure BP due to 
lymphedema etc.  
-108 participants, 37 lost 
to follow up 
-Mean age of 64, mean 
BMI 28, no baseline 
variation in results 
-Primary outcome BP, 






- Intervention received 
3-hour education 4 
weeks after screening 
event with 
multidisciplinary team 
and a booklet, 
reevaluated 4 months 
later 
-paired t test, chi-square 
test for data, p <0.05 







-BP reduced in 
intervention group of 17 
in SBP and 7 in DBP, p 
<0.001 
-Sign. reduction in 
weight of 7kg in 
intervention group 
-Short term education 
improved BP, lifestyle 
and HTN knowledge in 
patients.  
-Limitations- screened 
patients in community, 
may have missed 
patients with HTN or 
included patients with 
white coat syndrome 
-Self reported data 
open to recall bias and 
social desirability 
responses could affect 
results 
-Small sample size and 
short follow up, with 









Assess if aerobic 
exercise reduces 
BP in resistant 
HTN 
-Participants recruited 
from HTN outpatient 
clinic 
-Inclusion- BP >140/90 + 
3 meds or controlled on 
4 meds 
-Exclusion- already 
exercising, change in 
meds during study, 
comorbidities 
- Daytime ABP reduced 
5.9/3.3 
-Office BP no sign. 
reduction 
- Sign. improvement in 
physical performance 
and workload 
-Aerobic exercise has a 
statistical and clinical 








randomly assigned to 
control group or 
intervention group of 
exercise for 8-12 weeks 
of treadmill 3x/week 
-Primary outcome ABP, 
physical performance, 
arterial elasticity 
-Mean age 62.8 and 67.9 
for women and men 
-Chi squared and 
ANCOVA used based on 
data, p<.05 and <.01 
used 
- 3 participants lost to 
f/u 
-Population mean age is 
higher, and excluded 
patients with 






Evaluate the main 
studies assessing 
the effect of 
weight loss on BP 
-13 studies included, 
inclusion and exclusion 
criteria not discussed, 
unknown databases 
-Assessed studies both 
interventional and 
observational that 
looked at weight loss 
from diet, lifestyle 
changes, medications 
and surgery and effect 
on BP 
-All studies showed 
weight loss and reduced 
BP 
-Lifestyle modification 
studies showed a range 
of 0.3-8.7 kg weight loss 
and reduction in SBP of 
4.76-16.1 




sample sizes, different 

















of four 45 min. 
education sessions and 
worksheet of achievable 
goals 
-Inclusion criteria: 40-70 
y.o., live with family, 
reside in a city in Iran, 
HTN diagnosed longer 
than 1 yr. and confirmed 
by cardiologist, no 
cognitive impairment, 
no recent education for 




Wilk test, t-test, chi 
squared, Kolmogorov-
-Self-care score 
increased from 48.9 to 
59.7 in intervention 
group, increased 




























-Males 20 y.o. and older, 
BP 140/90 and higher or 
on HTN medication 
-984 smokers, light 1-10 
cig/day, med 11-20 
cig/day, heavy > 20 
cig/day 
-Measured CRP, IL-6, 
MCP-1, IL-1B, TNF-a, 
VCAM-1 
-chi-squared, means + 




- > 20 cig/day had sig. 
higher risk of HTN 
-Increased CRP levels 
with increased cig/day 
-Limitations: small 
power, all males, self-
report, selection bias 
GRADE-
C 






the effect of BP 
on risk of 
cardiovascular 
and all cause 
mortality in 
patients with HTN 




F/U 8.2 yrs 
-Random sampling 
-Inclusion: 40 y.o. or 
older, BP 140/90 or 
higher and/or HTN meds 
-36,943 participants 
-Light smoker 0.1-9 pack 
years, moderate 10-19 
pack years, heavy 20 
pack years or higher 
-Smoking prevalence 
57.6% men, 15.4% 
women 
-Cox proportional 
hazards, relative risks, 
95% confidence intervals 
-Increased pack years 
and BP increased risk of 
CVD and all cause 
mortality in HTN 
patients 
-CVD mortality 
increased 1.1-1.4 fold 
-Limitations: did not 



















-100 participants from 
an emergency room 
-Inclusion criteria: HTN, 
BP>140/85, 35-80 years 
old, not staff of ER, no 
cognitive issues, 
admitted to ER, 




for education group and 
education with follow 
up groups, p<0.001 
-Limitations: small 
sample size in each 










and 6 weeks after 
intervention 
-One 30-45 min. 
education session with 
weekly follow up by 
telephone verbally or 
written for 6 weeks 
-Kolmogorov-Smirnov 
test, chi squared, 
















-Block randomization of 
180 participants with 
HTN 
-Group A 8 education 
sessions, Group B 4 
pamphlets, Group C 8 
SMS messages, and 
Group D Usual care 
-Inclusion criteria: >18 
y.o., Stage 1 HTN, 
Iranian 
-Exclusion criteria: acute 
disease 
-Students paired t-test, 
ANOVA, chi squared, 
Wilcoxan Rank 
-Group A & B increased 
vegetable consumption 
-Group A increase in 
medication adherence 
-Decrease in SBP 
Groups A, B, & C 
-Decrease in DBP Group 
A 
-SBP decrease of 8.18, 
DBP decrease of 3.89 in 




















adherence and BP 
management 
-Outpatient clinic, 
diagnosed with HTN for 
more than a year, on 
medication, >35, 
BP>140/90, literate, able 
to communicate, no 
comorbidities that 
would prevent follow up 
-120 patients 
randomized to Group A, 
Group B, Control 
-Group A intervention of 
6 education sessions by 
a nurse on medication 
adherence, Group B 
intervention of 6 
monthly education 
sessions on medication 
adherence and lifestyle 
modifications, control 
-Statistical reduction in 
BP for Group A, Group 
B, greater in Group B 
- Statistical increase in 
MASES score for 
increased medication 
adherence in Group A 
and B 
-Statistical decrease in 
Group B BMI compared 
to control 
-Statistical increase in 




program improved the 
BP of patients with HTN 
-Good design and 
randomization allow 






group 6 f/u’s for BP 
check 
-Preintervention BP, 
height, weight, BMI, 
MASES scale for 
medication adherence 
and HPLP for lifestyle 
promotion. Measured 
again post intervention 
after 6 months.  
-No differences between 
groups pretest 
-Chi squared, ANOVA 
and paired t test used 
for data 
-P level of <0.005 used 
 
consider longer follow 
up to see how effects 
CV outcomes and 
increased sample size 







validate a new 
tool, HBP-SCP, in 
a sample of inner-
city residents 
-Pilot testing with 16 
participants 
-Content validity with 12 
experts 
-Based on Orem Self-
Care model and 
motivational 
interviewing 
-6th grade reading level 




-213 participants, 18 y.o. 
or older, English 
language, on HTN meds 
-Mean age 68.6, 76.1% 





correlations 0.2-0.63 for 
Behavior scale, 0.46-0.7 
for Motivation scale, 
0.4-0.74 for self-efficacy 
scale 
-4 questions with low 
factor loading, question 











term effect of 
modest sodium 
reduction on BP 
and blood levels 




reference lists up to 
2012 
-RCT’s with no co-
interventions, 18 and 
older, no DM or HF, and 
documented reduction 
in urine sodium levels 
-No language 
restrictions 
-Primary outcome is 
change in BP and urinary 
sodium excretion 
-Reduction on BP of 
5.39/2.8 in hypertensive 
patients 
-Reduction on BP of 
2.42/1.00 in 
normotensive patients 
-6 g/day reduction in 
sodium reduced SBP by 
5.8, p-value <.001 
- Results significant no 
matter gender or 
ethnicity 
-Sodium restriction 







-3252 studies narrowed 
to 34 studies by 2 
reviewers 
-Mean age of 
participants was 50 
-Mean sodium reduction 
was 4.4g/day 
-6.7% lost in follow up 
-Meta regression shows 
dose response 
relationship in sodium 
reduction and BP  
-Potential for 
confounding, would 
have been reduced with 
use of IPD 
-Short follow up of 4 







Examine effect of 
DASH trial on 
patients with and 
without M.S. 
-99 participants with 
metabolic syndrome 
(M.S.), 311 without M.S. 
- Randomized to 8 
weeks of control diet, 
fruits and vegetables 
diet or DASH diet 
- Inclusion criteria: > 22 
years old, SBP < 160 and 
DBP 80-95, not on 
medication during trial 
-Exclusion criteria: 
poorly controlled DM, 
renal insufficiency, BMI 
>35, total cholesterol > 
260 
- Chi squared test, 
Wilcoxon’s rank-sum, 
Fisher’s, multiple linear 
regression model 
-Participants with M.S.: 
reduction in SBP of 5.5 
mm Hg for DASH diet, p 
0.006, F&V diet reduced 
SBP by 4.4 mm Hg, 67% 
had controlled HTN 
compared to 17% in 
control group 
-Participants without 
M.S.: reduction of 6.8 
mm Hg in SBP and 4.0 
mm Hg in DBP, F&V diet 
reduced SBP by 4.1 mm 
Hg and DBP by 1.6 mm 
Hg 
- Limitations: small 

















-Data collected from 
2010-2012 from 
National Korean survey 
-Excluded <20 years old, 
missing data or BP 
measurements 
-15,052 participants, 
mean age 44.3 in men 
and 44.1 in women 
-Chi squared, ANOVA 
testing 
-Drinking behavior based 
on AUDIT questionnaire 
-High risk drinkers 
linked with the highest 
prevalence of HTN 
-Adjusting for age HTN 
prevalence rates: 25.6% 
in low risk drinking and 
40.4% in high risk 
drinking in men (p < 
0.001) , 24.6% in low 
risk and 32.3% in high 
risk drinking in women 









effect of 2 diets- 
one based on the 
DASH diet and 
another higher in 
K and Mg (LNAHK 
diet) on BP for 
those on 
-Inclusion criteria- > 25 
years old, BP > or = to 
120/80 
-Exclusion criteria BP > 
160/80, cardiac event in 
last 6 months, DM with 
insulin dependence, 
Warfarin, Dilantin, eat 
-LNAHK diet reduced 
SBP by 6.2 mm Hg and 
DBP by 2.8 mm Hg, p 
0.036, in patients with 
antihypertensive 
medications 
-Limitations: post hoc 








out > 2 meals a week, 
drank > 30 drinks a 
week, quitting smoking, 
not willing to stop 
supplements 
- 2- 4 week interventions 
with 2- 2 week control 
diet sessions 
-94 participants 
completed DASH diet, 43 
completed LNAHK diet 








Assess the effect 





-Outpatient, 22 and 
older, SBP 120-159 and 
DBP 80-95 
-Exclusion taking HTN 
medication, insulin use, 
increased ETOH use, 
CKD, HF 
-412 participants 
randomized to control of 
regular diet with low, 
medium and high 
sodium intake or 
intervention DASH diet 
with low, medium and 
high sodium intake 
-Meals and snacks were 
provided 
-Primary outcome SBP 
-2% lost to f/u 
-Linear regression 
studies used since based 
on previously collected 
data, with p<.001 
-Low sodium 
intervention group 
reduced SBP by 
5.3/7.48/9.7/20.79 for 
baseline SBP of <130, 
130-139, 140-149, 150 
and higher 
- DASH diet with low 
sodium showed a 
statistically significant 
reduction in SBP with 
response increasing 
with elevated baseline 
SBP 
-Exclusions may limit 
generalizability 
-Fewer participants in 
baseline SBP of 150 or 
greater so may affect 
results 

















-45 participants in 
control and 46 
participants in 
intervention group 
-Inclusion criteria: 60-65 
y.o., HTN diagnosis, no 
communication or 
cognitive disorder 
-Intervention was 2 
educational sessions, 
control received a 
pamphlet 
-Intervention group had 
improved knowledge of 
HTN, perceived benefits 
of control of HTN and 
decreased perception of 
barriers to control 
-Limitations: 
convenience sampling, 


















in women with 
HTN 
-64 participants, mean 
age 49.1 and 51.2 
-Intervention received 
four education sessions, 
self-care card and 
booklet 
-Utilized the H-SCALE 
-Chi squared, Mann 




improvement in diet, 
weight setting, sodium 
consumption, SBP and 
DBP in intervention 
group 
-SBP dropped from 













on Roy Adaption 
Model for HTN 
management 
-80 control participants, 
75 intervention 
participants, > 70% 
female 
-Recruited on certain 
days from Family Health 
centers 
-Inclusion criteria: HTN 
diagnosed, 35 or older, 
can perform own ADL’s 
-Intervention underwent 






-HTN management form 
and booklet 
-Chi squared, means, 
dependent t-test, 
independent t-test 
-Significant change in 
self-efficacy scores 
-Reduction in mean BP 
from 149.40 to 139.80 
-Limitations: 
convenience sampling, 










of HTN-SCP in 
English speaking 
Asian population 
-Primary care clinic, 
Singapore 
-Multiethnic Asian 
citizens or residents, Dx 
of HTN, 40 years or 
older, proficient in 
English, access to 
internet 
-Exclusion: known 
cognitive or visual 
impairment 




-HTN-SCP chosen based 
on multidomain, specific 
to HTN 
- Cronbach’s alpha 
0.857 Behavior scale, 
0.948 motivation scale, 
0.931 self-efficacy scale 
-Item 15 had poor item 
total correlation 
-ICC 0.671 behavior 
scale, 0.762 motivation 
scale, 0.720 self-efficacy 
scale 
-Limitations: Response 








questionnaire twice, 2 
weeks apart 
-Chi-squared, Mann 











Assess the effects 
of weight loss on 
BP in obese 
patients with 
newly diagnosed 
stage 1 HTN 
-Outpatient clinic, 
BMI>30, recent 
diagnosis of HTN but no 
medications, DM, CVD, 
secondary HTN, sleep 
apnea and other 
comorbidities 
-108 patients, assessed 
BP, BMI, waist 
circumference before 
and after intervention of 
weight loss diet and 
sodium restriction, 
monthly telephone 
contact and education 
-46 males, 62 females, 
mean age of 52 and 50 
-3.6% lost to follow up 
-T test and ANOVA used 
for data 
-Reduction in BMI, 
p<.001 
-Reduction of SBP in 





-Short term weight loss 
can reduce BP 
-No randomization, 
pre/post test 
-Small sample size may 
affect results and short 
f/u limit long term 
effect inferences 
-Exclusion of patient’s 










specific effects of 
smoking and BP 
levels on risk of 
death from CVD 
and stroke 
-Kangwha Cohort Study, 
Korea 
-Residents, 55 y.o. and 
older, BP greater than or 




f/u at longest 
-Smoking prevalence 
74.5% in men, 22.7% in 
women 
-One-way analysis of 
variance, chi-squared, 




increased risk of 
mortality from CVD or 
stroke, higher in men 
than women 
-Smoking status and BP 
association not 
statistically sign. 
-Limitations: quantity of 
smoking not defined, BP 
only measured at 
baseline, no info on 


















Google Scholar for 
studies that assessed 
impact of non-
-DASH diet showed 
reduction in BP with 
greatest reduction in 
hypertensive patients  
-Sodium reduction 







interventions on BP 
-No identification of 
inclusion criteria or p-
values from studies 
-No meta-analysis 
completed for each 
group, reported each 
study’s individual 
findings 
-DASH + Sodium 
reduction reduced BP 
-Potassium 
supplementation 
reduced BP on a meta-
analysis study 
-Physical activity meta-
analysis study showed 
reduction in BP for 
exercise of 150 
min/week 
-Weight loss + sodium 
restriction showed BP 
reduction 
-Weight loss + sodium 
restriction + exercise 
found to reduce BP 
-Non-pharmacologic 
measures reduce BP 
-Difficulty in 
determining significance 
and validity since most 
p values not reported 
Ozoemen
















from 2 areas with high 
rates of retirees, >60 
years old, excluded 
those ill prior to study 
-400 participants, 200 
male, 200 females 





attended 12 weekly 
education sessions 60 
min each, booklets, 
videos, charts 
-Control group received 
a health talk 
-Measurements of BMI, 
BP and 30 item 
questionnaire of HTN 
knowledge, self-care, 
sleep completed pre and 
post intervention 
-Mean age 65.9, mean 
SBP 136.5, mean DBP 
87.9, mean BMI 23.9 
-No sig. differences in 
baseline evaluations, 
-Increase in treatment 
group knowledge of 
HTN, p<0.0001 
-Increase in physical 
activity in treatment 




healthy diet, p=0.000, 
medication adherence, 
p=0.000 at 1 month and 




measures, no reported 
effect on BP or BMI 
-Consider RCT in future 
for more 
generalizability 
-Dropouts from study 
majority males 
-Report bias from self-
care/knowledge 
questionnaire 








women than men in 
treatment group 
-T test, chi-square, 
ANOVA test used for 
data, p<0.05 
to younger patients 
needs tested 





















of 47 nursing home 
residents to intervention 
or control 
-60 year or older, 
medical diagnosis of 
HTN more than 1 year 
before moving into 
nursing home, no severe 
cognitive deficit, optimal 
medications for HTN 
-Intervention- weekly 
health education 
sessions and tailored 
counselling for 8 weeks 
-Primary outcomes BP, 
self-care behavior, 
exercise self-efficacy and 
medication adherence 
-Mean age 77.4, women 
72% of participants, men 
28% 
-T-tests and chi squared 
tests, p value of <0.05 
used 
-Sign. reduction in BP 
for intervention group 
-Sign. increase in self-
care behavior, exercise 
self-efficacy in 
intervention group 




patients in nursing 
home would limit 
generalizability 
-Short term follow up of 









diet and exercise 
intervention on 
patients with type 
2 DM and 
uncontrolled HTN 
on BP 
-Outpatients with T2DM 
and BP >140/90, 
BMI<40.1, serum 
creatine <176 
-Exclusion- night shift 
work, disability, 
secondary causes of 
HTN, BP>180/120 
-40 participants, 
randomized to 4 weeks 
of control or 
intervention 
- Control educated on 
diabetic diet and 
provided pedometer 
-Intervention educated 
on DASH diet, walk 15-
20 more min/day, 
pedometer provided, 
meet with dietician and 
physical educator 
-Reduction in ABP of 
12/11 in intervention 
group, p=0.000 
- 55% of intervention 
group reached control 
in BP, p=0.008 
- DASH diet plus 
increased walking 
reduced the SBP and 
DBP both statistical and 
clinical significance 
- Limitation due to short 
follow up of 4 weeks, 
need further studies to 
assess long term benefit 







-Chi squared, student t 
test and Mann-Whitney 












Effect of alcohol 
reduction on BP 




Embase, Cochrane and 
Clinicaltrials.gov from 
inception to 7/13/16 
-Limited to full text, 
human trials, change in 
ETOH consumption and 
BP 
- No language 
restrictions 
- Authors not contacted 
-2320 initial studies 
narrowed to 36 by 2 





differences, p<0.1 used 
for statistical analysis 
-Significant between 
study heterogeneity 
- 2 or fewer drink a day, 
no stat. sig. change in 
SBP 
- 3 drinks a day reduced 
to near abstinence, stat. 
sig reduction of 1.18 
SBP/1.09 DBP (may not 
clinically significant) 
-6 drinks or more a day 
reduced by 50%, stat. 
sig reduction of 5.5 
SBP/3.97 DBP 
- P value is too high at 
0.1 
- included normotensive 
patients in study, may 
affect result when 
looking only at patient’s 
with HTN 
-2464 men and only 401 
women, may affect 
















effect of the 
DASH diet on BP 
-Searched PubMed, ISI 
Web of Science, Scopus, 
Google scholar up to 
June 2013, contacted 
authors if needed 
-RCT’s that implemented 
DASH diet through 
education or food 
supplied in parallel or 
cross-over studies 
- No language restriction 
-1224 studies narrowed 
to 17 studies by 2 




-P value of <0.05 for 
significance 
-Tests showed risk for 
publication bias 
- SBP and DBP reduction 
of 6.74/3.54 
-Higher baseline BP 
produced a greater 
reduction in post 
intervention BP 
-DASH diet reduces SBP 
and DBP 
- Diet was not 
homogenous across 
studies and may affect 
results and 
implementation 
- Studies included both 
normotensive and 
hypertensive patients, 
may affect application 
to only hypertensive 













of exercise on 
resistant HTN 
-Participants: 25-60 
years old, diagnosed 
with HTN, taking at least 
3 meds and not 
controlled BP, no change 
in meds while on study, 
no restrictions to 
exercise 
-Excluded: controlled BP 
on medications 
-Randomized to 45 
minutes of rest, light or 
moderate exercise 
-20 participants 
-5hour SBP reduced by 
7.7 in light exercise and 
9.4 in moderate 
exercise 
-Light session had 
sustained reduction BP 
19 hours later 
-Limitations: sample 














-156 participants, 28 lost 
to follow up 
-BP measured baseline, 
6, 12,18 and 24 months 
-Medication adherence 
assessed at baseline, 6 
and 24 months 







participants had SBP 6.3 
higher at baseline, 8.4 
higher at 12 months, 7.5 
higher at 24 months, p < 
0.05 
-Limitations: secondary 










on HBPM and 
application for 
clinical practice 
-No information on 
article selection process, 
inclusion and exclusion 
criteria 
-HBPM results in better 
medication adherence 
and higher control rates 
-Mixed results on HBPM 
compared to ABPM and 
clinic BP 
-Less expensive and 










and HTN in 
Vietnamese men 
-910 participants, male, 
in Can Tho Vietnam, 25-
64 years old, BP > or 
equal to 140/90 
-Questionnaire 
-67.8% current smokers, 
13% ex-smokers, 19.2% 
non-smokers 
-Poisson regression, 95% 
confidence interval 
-Longer duration of 
smoking and increased 
lifetime cigarette 
consumption associated 
with increased HTN 
prevalence 
-Ex-smokers higher BP 
than non-smokers 
-Limitations: all men, 






















articles published since 
2000, contacted authors 
for IPD 
-RCT’s comparing self-
monitoring to no 
intervention in 
outpatients, f/u for at 
least 24 wks 
- 1224 studies narrowed 
to 25 by 2 reviewers, 
10,487 patients 
-Primary outcome BP, 
control of HTN 
-Significant between 
study heterogeneity 
-10% of participants lost 
in follow up 
-Only CI listed at 95%, 
the p value for results 
not reported 
- 12 month follow up 
measurements, average 
reduction BP of 3.2/1.5 
-Studies with no co-
intervention reduction 
of BP 1/1.1 
-Studies with personal 
support, co-
interventions reduction 
of BP 6.1/2.3 
- Reduction in BP found 
with self-monitoring 
with co-interventions 
-Self-monitoring may be 
beneficial with other 
interventions but does 
not show much change 
as only intervention. 
Grade-B 








incidence of HTN 
-Analyzed data from 2 
large studies in Korea 
-8,720 participants 
included; ages 40-69 
years old 
-ANOVA, Duncan’s post 
hoc test, chi squared, 
Cox regression analysis, 
Kaplan-Meier survival 
analysis, Log rank test 
-Men: moderate to high 
consumption correlated 




with increased HTN 
prevalence 
-10 year follow up 
showed increased 
development of HTN 
with any alcohol 
consumption, but risk 
increased with alcohol 
consumption patterns 
-Limitations: post hoc, 























- Inclusion diagnosed 
HTN and on medications 
for at least 1 month 
-Exclusion- speak 
different language, 
severe acute illness 
-256 patients, 23 
dropped out of study, 
mean age 65 
-26.3% had low 
adherence, 22% had 
medium adherence, 
51.7% had high 
adherence to 
medications 
-Mean SBP 135.2 in high 
adherence, and 143.3 in 
low adherence, p<0.001 
-Knowledge of HTN, 










-participants filled out 
the 8 item MMAS scale 
to assess medication 
adherence and 
researcher designed 
questionnaire for risk 
factors for medication 
non-adherence 
-BP checked 3 times, 
patient sitting, averaged 
-Chi squared, student t 
test and Mann Whitney 




has a significant 
decrease in SBP 
compared to low 
adherence 
-Possible self-report 





Appendix B- Hypertension Self-Care Profile Behavior Questionnaire 
Listed below are common recommendations for persons with hypertension. How often do you 
do the following? 
Items Always Frequently Sometimes Rarely/ 
Never 
1. Take part in regular physical activity (e.g. 30 
minutes of walking 4-5 times a week)? 
4 3 2 1 
2. Read nutrition facts label to check 
information on sodium content? 
4 3 2 1 
3. Replace traditional high-salt foods (e.g. 
canned soups, Oodles of Noodles) with low-
salt products (e.g. homemade soups, fresh 
vegetables)? 
4 3 2 1 
4. Limit use of high-salt condiments (e.g. 
Ketchup)? 
4 3 2 1 
5. Eat less than 1 teaspoon of table salt per 
day (6 grams)? 
4 3 2 1 
6. Eat less foods that are high in saturated 
(e.g. red meat, butter) and trans-fat (e.g. 
shortening, lard)? 
4 3 2 1 
7. Use broil, bake or steam instead of frying 
when cooking? 
4 3 2 1 
8. Read nutrition facts label to check 
information on saturated (e.g. butter, red 
meat) and trans-fat (e.g. lard, shortening)? 
4 3 2 1 
9. Replace traditional high-fat foods (e.g. 
deep-fried chicken) with low-fat products (e.g. 
baked chicken)? 
4 3 2 1 
10. Limit total calorie intake from fat (less 
than 65 grams) daily? 
4 3 2 1 
11. Eat 5 or more servings of fruits and 
vegetables daily? 




12. Practice moderation in drinking alcohol 
daily (2 glasses or less for men; 1 glass or less 
for women)? 
4 3 2 1 
13. Practice non-smoking? 4 3 2 1 
14. Check your blood pressure at home? 4 3 2 1 
15. Forget to take your blood pressure 
medicine? 
1 2 3 4 
16. Forget to fill your prescriptions? 1 2 3 4 
17. Keep your weight down? 4 3 2 1 
18. Monitor situations that cause a high level 
of stress (e.g. arguments, death in the family) 
resulting in blood pressure elevation? 
4 3 2 1 
19. Engage in activities that can lower stress 
(e.g. deep breathing, meditation)? 
4 3 2 1 




















The project sounds exciting and I grant your request to use HBP SCP for your DNP project. 
Please kindly share any relevant project info (e.g., design, sample size, inclusion/exclusion, 
setting, outcomes) when available for my recording purpose. Best wishes, Haera 
  
Hae-Ra Han, PhD, RN, FAAN I Isabel Hampton Robb Professor  
“hera han”| she/her/hers 
Johns Hopkins School of Nursing 
Joint Appointment with the Department of Health, Behavior, and Society 
Johns Hopkins Bloomberg School of Public Health 
525 N. Wolfe Street, Baltimore, MD  21205 
P. 410-614-2669 | F. 410-502-5481 | E. hhan3@jhu.edu 




















Appendix D- Informed Consent 
 
 
INFORMED CONSENT  
Department of Nursing 
   
TITLE OF STUDY: Improving Self-Care Measures of Hypertension Through Implementation 
of an Education and Action Plan 
INVESTIGATOR(S): Crystal Huffaker and Cheryl Maes 
For questions or concerns about the study, you may contact Crystal Huffaker at (702) 837-1265 
For questions regarding the rights of research subjects, any complaints or comments regarding 
the manner in which the study is being conducted, contact the UNLV Office of Research 
Integrity – Human Subjects at 702-895-2794, toll free at 888-581-2794 or via email at 
IRB@unlv.edu 
   
 
Purpose of the Study 
You are invited to participate in a project. The purpose of this project is to improve participants’ 
knowledge of self-care measures for hypertension and encourage adoption of these self-care 
measures through the development of individualized goals. 
 
Participants 
You are being asked to participate in the project because you fit this criterion: 35-55 years old, 
have a diagnosis of essential hypertension, currently prescribed one or more antihypertensive 
medications, not pregnant, able to read and speak English, and attended a clinic visit at M Family 
Care within the last 12 months. 
 
Procedures  
If you volunteer to participate in this project, you will be asked to do the following: complete a 
demographic questionnaire and self-care of hypertension questionnaire, have your height, weight 
and blood pressure measured, participate in an individual education session for 30-40 minutes, 
receive 2 follow-up phone calls 1 and 2 months after the education session and attend an in-
person follow up.   
  
Benefits of Participation  
There will be direct benefits to you as a participant in this project you will receive education 






Risks of Participation  
There are risks involved in all research studies/projects. This project may include only minimal 
risks. This includes that you may feel uncomfortable answering some questions and you may feel 
some physical discomfort while sitting during the education session.  
 
Cost /Compensation  
There will be no financial cost to you to participate in this project. The project will take a total of 
110-120 minutes of your time over the course of 4 separate days during the next 12 weeks. You 
will not be compensated for your time.    
 
Confidentiality  
All information gathered in this project will be kept confidential.  No reference will be made in 
written or oral materials that could link you to this project. All records will be stored in a locked 
box and will be destroyed once the project is complete.  
 
Voluntary Participation  
Your participation in this project is voluntary. You may refuse to participate in this project or in 
any part of this project. You may withdraw at any time without prejudice to your relations with 
UNLV or M Family Care. You are encouraged to ask questions about this project at the 
beginning or any time during the project.   
 
Participant Consent:  
I have read the above information and agree to participate in this project. I have been able to ask 




             
Signature of Participant                                             Date  
 
        









Appendix E- Demographic Sheet 
Age: (Please circle which age group applies to you) 
35-44  45-55   
Gender:  
Male    or     Female  
Highest Education Level: (Please circle which applies to you) 
No schooling  Some high school  High school graduate or equivalent      
Some college  Vocational training  Associate degree Bachelor’s degree  
Master’s degree Doctorate degree 
 
Initial Visit Biometrics: 
Height: ____________ inches 
Weight: ____________ lbs. 
BMI: _____________ 
BP readings: ______/_______     ______/______ Average: ______/______ 
 
3 Month Follow-up Visit Biometrics: 
Height: ____________ inches 
Weight: ____________ lbs. 
BMI: _____________ 





































































































Appendix J- Timeline for DNP project 
Timeframe Action 
Prior to implementation Complete defense of project proposal 
Obtain IRB approval 
Placement of flyers for recruitment one month prior to study start 
Week 1 through Week 2 Contact participants who meet inclusion criteria to participate in 
quality improvement project 
Week 2 through Week 4 Initial visit with participants: 
 Obtain informed consent 
 Demographic questionnaire completed 
 Biometrics obtained 
 Participant complete HBP-SCP questionnaire 
 Individual 30-40 min education session  
 Completed patient action plan 
Week 6 through Week 8 1-month follow-up phone call 
               Assess participant compliance with action plan 
               Answer questions or concerns regarding HTN, 
medications or                            
               lifestyle changes 
Week 10 through Week 12 2-month follow-up phone call 
               Assess participant compliance with action plan 
               Answer questions or concerns regarding HTN, 
medications or                            
               lifestyle changes 
Week 14 through Week 16 3-month in person follow-up 
 Remeasure biometrics 
 Participant complete HBP-SCP  
 Evaluate progress on goals 























Appendix M- Results of HBP-SCP Behavior Scale Questions 1-20 
Question 1. Take part in regular physical activity? 






Frequency % Frequency % Frequency % 
Rarely/Never 7 18.9 2 9.5 2 9.5 
Sometimes 16 43.2 13 61.9 5 23.8 
Frequently 8 21.6 4 19.0 9 42.9 
Always 6 16.2 2 9.5 5 23.8 
Total 37 100 21 100 21 100 
 
Question 2. Read nutrition facts label to check information on sodium content? 






Frequency % Frequency % Frequency % 
Rarely/Never 13 35.1 5 23.8 3 14.3 
Sometimes 12 32.4 8 38.1 5 23.8 
Frequently 7 18.9 5 23.8 8 38.1 
Always 5 13.5 3 14.3 5 23.8 
Total 37 100 21 100 21 100 
 
Question 3. Replace traditional high-salt foods with low salt products? 






Frequency % Frequency % Frequency % 
Rarely/Never 4 10.8 2 9.5 1 4.8 
Sometimes 16 43.2 8 38.1 4 19.0 
Frequently 12 32.4 9 42.9 7 33.3 
Always 5 13.5 2 9.5 9 42.9 
Total 37 100 21 100 21 100 
 
Question 4. Limit use of high-salt condiments? 






Frequency % Frequency % Frequency % 
Rarely/Never 11 29.7 6 28.6 2 9.5 




Frequently 10 27.0 6 28.6 9 42.9 
Always 7 18.9 4 19.0 5 23.8 
Total 37 100 21 100 21 100 
 
Question 5. Eat less than 1 teaspoon of table salt per day? 






Frequency % Frequency % Frequency % 
Rarely/Never 12 32.4 4 19.0 2 9.5 
Sometimes 12 32.4 7 33.3 7 33.3 
Frequently 9 24.3 8 38.1 8 38.1 
Always 4 10.8 2 9.5 4 19.0 
Total 37 100 21 100 21 100 
 
Question 6. Eat less foods that are high in saturated and trans-fat? 






Frequency % Frequency % Frequency % 
Rarely/Never 10 27.0 4 19.0 1 4.8 
Sometimes 16 43.2 12 57.1 10 47.6 
Frequently 10 27.0 5 23.8 8       38.1 
Always 1 2.7 0 0 2 9.5 
Total 37 100 21 100 21 100 
 
Question 7. Use broil, bake or steam instead of frying when cooking? 






Frequency % Frequency % Frequency % 
Rarely/Never 0 0 0 0 0 0 
Sometimes 11 29.7 5 23.8 3 14.3 
Frequently 18 48.6 11 52.4 12 57.1 
Always 8 21.6 5 23.8 6 28.6 
Total 37 100 21 100 21 100 
 
Question 8. Read nutrition facts label to check information on saturated and trans-fat? 









Frequency % Frequency % Frequency % 
Rarely/Never 13 35.1 5 23.8 4 19.0 
Sometimes 8 21.6 6 28.6 5 23.8 
Frequently 10 27.0 6 28.6 4 19.0 
Always 6 16.2 4 19.0 8 38.1 
Total 37 100 21 100 21 100 
 
Question 9. Replace traditional high-fat foods with low-fat products? 






Frequency % Frequency % Frequency % 
Rarely/Never 2 5.4 0 0 0 0 
Sometimes 20 54.1 12 57.1 4 19.0 
Frequently 7 18.9 5 23.8 13 61.9 
Always 8 21.6 4 19.0 4 19.0 
Total 37 100 21 100 21 100 
 
Question 10. Limit total calorie intake from fat daily? 






Frequency % Frequency % Frequency % 
Rarely/Never 13 35.1 7 33.3 4 19.0 
Sometimes 16 43.2 9 42.9 9 42.9 
Frequently 7 18.9 5 23.8 7 33.3 
Always 1 2.7 0 0 1 4.8 
Total 37 100 21 100 21 100 
 
Question 11. Eat 5 or more servings of fruits and vegetables? 






Frequency % Frequency % Frequency % 
Rarely/Never 9 24.3 4 19.0 0 0 
Sometimes 16 43.2 10 47.6 8 38.1 
Frequently 11 29.7 7 33.3 11 52.4 
Always 1 2.7 0 0 2 9.5 
Total 37 100 21 100 21 100 
 










Frequency % Frequency % Frequency % 
Rarely/Never 2 5.4 1 4.8 0 0 
Sometimes 8 21.6 4 19.0 1 4.8 
Frequently 6 16.2 3 14.3 5 23.8 
Always 21 56.8 13 61.9 15 71.4 
Total 37 100 21 100 21 100 
 
Question 13. Practice non-smoking? 






Frequency % Frequency % Frequency % 
Rarely/Never 2 5.4 1 4.8 0 0 
Sometimes 1 2.7 0 0 0 0 
Frequently 1 2.7 0 0 1 4.8 
Always 33 89.2 20 95.2 20 95.2 
Total 37 100 21 100 21 100 
 
Question 14. Check your blood pressure at home? 






Frequency % Frequency % Frequency % 
Rarely/Never 8 21.6 3 14.3 0 0 
Sometimes 17 45.9 12 57.1 10 47.6 
Frequently 5 13.5 2 9.5 6 28.6 
Always 7 18.9 4 19.0 5 23.8 
Total 37 100 21 100 21 100 
 
Question 15. Forget to take your blood pressure medication? 






Frequency % Frequency % Frequency % 
Rarely/Never 1 2.7 0 0 0 0 
Sometimes 2 5.4 1 4.8 0 0 
Frequently 5 13.5 2 9.5 2 9.5 
Always 29 78.4 18 85.7 18 90.5 





Question 16. Forget to fill your prescriptions? 






Frequency % Frequency % Frequency % 
Rarely/Never 0 0 0 0 0 0 
Sometimes 0 0 0 0 0 0 
Frequently 5 13.5 2 9.5 1 4.8 
Always 32 86.5 19 90.5 20 95.2 
Total 37 100 21 100 21 100 
 
Question 17. Keep your weight down? 






Frequency % Frequency % Frequency % 
Rarely/Never 4 10.8 1 4.8 1 4.8 
Sometimes 23 62.2 13 61.9 10 47.6 
Frequently 6 16.2 5 23.8 6 28.6 
Always 4 10.8 2 9.5 4 19.0 
Total 37 100 21 100 21 100 
 
Question 18. Monitor situations that can cause a high level of stress? 






Frequency % Frequency % Frequency % 
Rarely/Never 6 16.2 3 14.3 2 9.5 
Sometimes 16 43.2 10 47.6 5 23.8 
Frequently 11 29.7 7 33.3 9 42.9 
Always 4 10.8 1 4.8 5 23.8 
Total 37 100 21 100 21 100 
 
Question 19. Engage in activities that can lower stress? 






Frequency % Frequency % Frequency % 
Rarely/Never 7 27.0 3 14.3 2 9.5 
Sometimes 14 37.8 9 42.9 12 57.1 
Frequently 14 37.8 8 38.1 6 28.6 




Total 37 100 21 100 21 100 
 
Question 20. See a doctor regularly? 






Frequency % Frequency % Frequency % 
Rarely/Never 0 0 0 0 1 4.8 
Sometimes 10 27.0 6 28.6 6 28.6 
Frequently 14 37.8 8 38.1 5 23.8 
Always 13 35.1 7 33.3 9 42.9 
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Academy of Nurse Practitioners, 22, 668-673.  
Certifications 2018-2022 
▪ BLS certification 
 
2008-Present 
▪ Family Nurse Practitioner, ANCC 
 
2005-2014  






▪ RN and APRN Active Prescribing – CII license for State of Nevada 
▪ Nevada Controlled Substance License 
 
2008-Present 
▪ DEA license 
Memberships 2020-Present 
▪ Sigma Theta Tau International Honor Society of Nursing 
 
Volunteer 2021 
▪ Help administer vaccinations for COVID-19 
 
2018 







▪ Teach children in Republic of Palau principles of self-reliance. 
Coordinate educational and fun activities for children. 
 
2006-2008 and 2018 
▪ Demonstrate BLS and first aid to 12-18 years old.  
 
